JP6068464B2 - γ−セクレターゼ調節剤としての新規な置換インドール誘導体 - Google Patents

Info

Publication number

JP6068464B2

JP6068464B2 JP2014519557A JP2014519557A JP6068464B2 JP 6068464 B2 JP6068464 B2 JP 6068464B2 JP 2014519557 A JP2014519557 A JP 2014519557A JP 2014519557 A JP2014519557 A JP 2014519557A JP 6068464 B2 JP6068464 B2 JP 6068464B2

Authority

JP

Japan

Prior art keywords

group

fluoro

alkyloxy

alkyl

formula

Prior art date

2011-07-15

Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Expired - Fee Related

Links

• Espacenet
• Global Dossier
• Discuss

• 229940054051 antipsychotic indole derivative Drugs 0.000 title description 2
• 150000002475 indoles Chemical class 0.000 title description 2
• 150000001875 compounds Chemical class 0.000 claims description 247
• 125000000217 alkyl group Chemical group 0.000 claims description 135
• 125000001424 substituent group Chemical group 0.000 claims description 110
• 125000003545 alkoxy group Chemical group 0.000 claims description 100
• 229910052739 hydrogen Inorganic materials 0.000 claims description 93
• 239000001257 hydrogen Substances 0.000 claims description 92
• 125000001153 fluoro group Chemical group F* 0.000 claims description 84
• 125000005843 halogen group Chemical group 0.000 claims description 76
• 150000003839 salts Chemical class 0.000 claims description 64
• 125000004093 cyano group Chemical group *C#N 0.000 claims description 60
• 150000002431 hydrogen Chemical class 0.000 claims description 59
• 229910052799 carbon Inorganic materials 0.000 claims description 53
• 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 53
• 208000024827 Alzheimer disease Diseases 0.000 claims description 49
• 125000004076 pyridyl group Chemical group 0.000 claims description 41
• 239000012453 solvate Substances 0.000 claims description 37
• UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 29
• 125000003226 pyrazolyl group Chemical group 0.000 claims description 29
• 125000006570 (C5-C6) heteroaryl group Chemical group 0.000 claims description 26
• 206010012289 Dementia Diseases 0.000 claims description 22
• 125000002883 imidazolyl group Chemical group 0.000 claims description 17
• 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 16
• 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 16
• 239000008194 pharmaceutical composition Substances 0.000 claims description 15
• 125000001376 1,2,4-triazolyl group Chemical group N1N=C(N=C1)* 0.000 claims description 14
• 201000010099 disease Diseases 0.000 claims description 14
• 125000002971 oxazolyl group Chemical group 0.000 claims description 12
• 102000013455 Amyloid beta-Peptides Human genes 0.000 claims description 10
• 108010090849 Amyloid beta-Peptides Proteins 0.000 claims description 9
• 229910052757 nitrogen Inorganic materials 0.000 claims description 9
• 208000005145 Cerebral amyloid angiopathy Diseases 0.000 claims description 6
• 206010061216 Infarction Diseases 0.000 claims description 6
• 208000030886 Traumatic Brain injury Diseases 0.000 claims description 6
• 208000010877 cognitive disease Diseases 0.000 claims description 6
• 208000017004 dementia pugilistica Diseases 0.000 claims description 6
• 239000003937 drug carrier Substances 0.000 claims description 6
• 230000007574 infarction Effects 0.000 claims description 6
• 208000027061 mild cognitive impairment Diseases 0.000 claims description 6
• 230000002265 prevention Effects 0.000 claims description 6
• 230000009529 traumatic brain injury Effects 0.000 claims description 6
• 201000010374 Down Syndrome Diseases 0.000 claims description 5
• 208000009829 Lewy Body Disease Diseases 0.000 claims description 5
• 201000002832 Lewy body dementia Diseases 0.000 claims description 5
• 208000018737 Parkinson disease Diseases 0.000 claims description 5
• 230000032683 aging Effects 0.000 claims description 5
• 238000006467 substitution reaction Methods 0.000 claims description 5
• 206010044688 Trisomy 21 Diseases 0.000 claims description 3
• 239000000543 intermediate Substances 0.000 description 465
• OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 264
• YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 161
• 239000000203 mixture Substances 0.000 description 126
• 238000002360 preparation method Methods 0.000 description 126
• 239000012071 phase Substances 0.000 description 112
• XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 111
• VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 111
• 239000011541 reaction mixture Substances 0.000 description 96
• 239000000047 product Substances 0.000 description 87
• 239000002904 solvent Substances 0.000 description 86
• 239000000243 solution Substances 0.000 description 84
• 238000000034 method Methods 0.000 description 75
• 239000012044 organic layer Substances 0.000 description 68
• 238000006243 chemical reaction Methods 0.000 description 64
• XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 64
• 108010064539 amyloid beta-protein (1-42) Proteins 0.000 description 63
• IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 62
• 238000007792 addition Methods 0.000 description 58
• 235000019439 ethyl acetate Nutrition 0.000 description 55
• WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 54
• ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 51
• 239000000377 silicon dioxide Substances 0.000 description 50
• WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 45
• -1 bicyclic imidazole derivatives Chemical class 0.000 description 45
• 239000003480 eluent Substances 0.000 description 45
• LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 44
• 238000003818 flash chromatography Methods 0.000 description 44
• KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 32
• 125000004448 alkyl carbonyl group Chemical group 0.000 description 32
• 229910052796 boron Inorganic materials 0.000 description 31
• 239000012043 crude product Substances 0.000 description 31
• HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 30
• VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 29
• 239000003795 chemical substances by application Substances 0.000 description 29
• 102000002659 Amyloid Precursor Protein Secretases Human genes 0.000 description 28
• 108010043324 Amyloid Precursor Protein Secretases Proteins 0.000 description 28
• 230000000694 effects Effects 0.000 description 28
• 238000004519 manufacturing process Methods 0.000 description 26
• 239000007787 solid Substances 0.000 description 26
• 241001465754 Metazoa Species 0.000 description 25
• YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 25
• 210000004556 brain Anatomy 0.000 description 25
• 239000002253 acid Substances 0.000 description 24
• 230000015572 biosynthetic process Effects 0.000 description 24
• 229920006395 saturated elastomer Polymers 0.000 description 24
• 238000003786 synthesis reaction Methods 0.000 description 24
• ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 23
• 239000012267 brine Substances 0.000 description 23
• 239000011734 sodium Substances 0.000 description 23
• HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 23
• HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 description 22
• 239000002585 base Substances 0.000 description 22
• 108010037444 diisopropylglutathione ester Proteins 0.000 description 22
• 238000005259 measurement Methods 0.000 description 22
• 239000008280 blood Substances 0.000 description 20
• 210000004369 blood Anatomy 0.000 description 20
• 239000010410 layer Substances 0.000 description 20
• 239000003814 drug Substances 0.000 description 19
• 239000006228 supernatant Substances 0.000 description 19
• QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 18
• KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 17
• 229910052801 chlorine Inorganic materials 0.000 description 17
• OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical compound NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 description 16
• 229910052794 bromium Inorganic materials 0.000 description 16
• 238000002474 experimental method Methods 0.000 description 16
• 239000007924 injection Substances 0.000 description 16
• 238000002347 injection Methods 0.000 description 16
• 239000002244 precipitate Substances 0.000 description 16
• 239000000725 suspension Substances 0.000 description 16
• RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 15
• 238000004808 supercritical fluid chromatography Methods 0.000 description 15
• 108010064397 amyloid beta-protein (1-40) Proteins 0.000 description 14
• 230000037396 body weight Effects 0.000 description 14
• 125000002757 morpholinyl group Chemical group 0.000 description 14
• 239000004480 active ingredient Substances 0.000 description 13
• HPNMFZURTQLUMO-UHFFFAOYSA-N diethylamine Chemical compound CCNCC HPNMFZURTQLUMO-UHFFFAOYSA-N 0.000 description 13
• 239000000706 filtrate Substances 0.000 description 13
• 125000006239 protecting group Chemical group 0.000 description 13
• WMFOQBRAJBCJND-UHFFFAOYSA-M Lithium hydroxide Chemical compound [Li+].[OH-] WMFOQBRAJBCJND-UHFFFAOYSA-M 0.000 description 12
• 239000003921 oil Substances 0.000 description 12
• 235000019198 oils Nutrition 0.000 description 12
• FVAUCKIRQBBSSJ-UHFFFAOYSA-M sodium iodide Chemical compound [Na+].[I-] FVAUCKIRQBBSSJ-UHFFFAOYSA-M 0.000 description 12
• 239000005909 Kieselgur Substances 0.000 description 11
• 210000004027 cell Anatomy 0.000 description 11
• 238000010511 deprotection reaction Methods 0.000 description 11
• 238000001514 detection method Methods 0.000 description 11
• 150000002148 esters Chemical class 0.000 description 11
• JJWLVOIRVHMVIS-UHFFFAOYSA-N isopropylamine Chemical compound CC(C)N JJWLVOIRVHMVIS-UHFFFAOYSA-N 0.000 description 11
• 239000003826 tablet Substances 0.000 description 11
• JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 description 10
• 238000001727 in vivo Methods 0.000 description 10
• BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 10
• 108090000765 processed proteins & peptides Proteins 0.000 description 10
• 238000000746 purification Methods 0.000 description 10
• 238000003756 stirring Methods 0.000 description 10
• VHNYOQKVZQVBLC-RTCGXNAVSA-N (4r,7e,9as)-7-[[3-methoxy-4-(4-methylimidazol-1-yl)phenyl]methylidene]-4-(3,4,5-trifluorophenyl)-1,3,4,8,9,9a-hexahydropyrido[2,1-c][1,4]oxazin-6-one Chemical compound C1([C@@H]2COC[C@@H]3CC\C(C(N32)=O)=C/C=2C=C(C(=CC=2)N2C=C(C)N=C2)OC)=CC(F)=C(F)C(F)=C1 VHNYOQKVZQVBLC-RTCGXNAVSA-N 0.000 description 9
• CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 9
• 241000124008 Mammalia Species 0.000 description 9
• FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 9
• 239000007864 aqueous solution Substances 0.000 description 9
• 239000011324 bead Substances 0.000 description 9
• 229960004853 betadex Drugs 0.000 description 9
• 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 9
• 238000010992 reflux Methods 0.000 description 9
• 229940124648 γ-Secretase Modulator Drugs 0.000 description 9
• IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 8
• 229920000858 Cyclodextrin Polymers 0.000 description 8
• 241000282412 Homo Species 0.000 description 8
• 241000699670 Mus sp. Species 0.000 description 8
• 241000700159 Rattus Species 0.000 description 8
• 238000003556 assay Methods 0.000 description 8
• WHGYBXFWUBPSRW-FOUAGVGXSA-N beta-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO WHGYBXFWUBPSRW-FOUAGVGXSA-N 0.000 description 8
• 239000002775 capsule Substances 0.000 description 8
• 210000001175 cerebrospinal fluid Anatomy 0.000 description 8
• LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 8
• 125000004435 hydrogen atom Chemical group [H]* 0.000 description 8
• 238000002844 melting Methods 0.000 description 8
• 230000008018 melting Effects 0.000 description 8
• 239000012299 nitrogen atmosphere Substances 0.000 description 8
• 229910052763 palladium Inorganic materials 0.000 description 8
• 239000002953 phosphate buffered saline Substances 0.000 description 8
• 210000002381 plasma Anatomy 0.000 description 8
• 238000012545 processing Methods 0.000 description 8
• 238000012360 testing method Methods 0.000 description 8
• 230000009261 transgenic effect Effects 0.000 description 8
• 239000003643 water by type Substances 0.000 description 8
• CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 7
• 102000015499 Presenilins Human genes 0.000 description 7
• 108010050254 Presenilins Proteins 0.000 description 7
• ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 7
• 230000014759 maintenance of location Effects 0.000 description 7
• 229910000104 sodium hydride Inorganic materials 0.000 description 7
• 238000010561 standard procedure Methods 0.000 description 7
• 239000007858 starting material Substances 0.000 description 7
• 239000000758 substrate Substances 0.000 description 7
• JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 7
• DTQVDTLACAAQTR-UHFFFAOYSA-N trifluoroacetic acid Substances OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 7
• 238000001195 ultra high performance liquid chromatography Methods 0.000 description 7
• 239000011701 zinc Substances 0.000 description 7
• QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 6
• IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 6
• 238000002965 ELISA Methods 0.000 description 6
• 102000005650 Notch Receptors Human genes 0.000 description 6
• 108010070047 Notch Receptors Proteins 0.000 description 6
• 238000006069 Suzuki reaction reaction Methods 0.000 description 6
• 238000004458 analytical method Methods 0.000 description 6
• 125000004429 atom Chemical group 0.000 description 6
• 239000000872 buffer Substances 0.000 description 6
• 125000004432 carbon atom Chemical group C* 0.000 description 6
• CSJLBAMHHLJAAS-UHFFFAOYSA-N diethylaminosulfur trifluoride Chemical compound CCN(CC)S(F)(F)F CSJLBAMHHLJAAS-UHFFFAOYSA-N 0.000 description 6
• UAOMVDZJSHZZME-UHFFFAOYSA-N diisopropylamine Chemical compound CC(C)NC(C)C UAOMVDZJSHZZME-UHFFFAOYSA-N 0.000 description 6
• 239000002552 dosage form Substances 0.000 description 6
• 150000002500 ions Chemical class 0.000 description 6
• 239000007788 liquid Substances 0.000 description 6
• MZRVEZGGRBJDDB-UHFFFAOYSA-N n-Butyllithium Substances [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 description 6
• VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 6
• 108090000623 proteins and genes Proteins 0.000 description 6
• 238000004007 reversed phase HPLC Methods 0.000 description 6
• 229940124597 therapeutic agent Drugs 0.000 description 6
• 238000005406 washing Methods 0.000 description 6
• KZPYGQFFRCFCPP-UHFFFAOYSA-N 1,1'-bis(diphenylphosphino)ferrocene Chemical compound [Fe+2].C1=CC=C[C-]1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=C[C-]1P(C=1C=CC=CC=1)C1=CC=CC=C1 KZPYGQFFRCFCPP-UHFFFAOYSA-N 0.000 description 5
• OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 5
• USFZMSVCRYTOJT-UHFFFAOYSA-N Ammonium acetate Chemical compound N.CC(O)=O USFZMSVCRYTOJT-UHFFFAOYSA-N 0.000 description 5
• 239000005695 Ammonium acetate Substances 0.000 description 5
• XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 5
• 239000001116 FEMA 4028 Substances 0.000 description 5
• 235000019257 ammonium acetate Nutrition 0.000 description 5
• 229940043376 ammonium acetate Drugs 0.000 description 5
• 239000006185 dispersion Substances 0.000 description 5
• 230000005284 excitation Effects 0.000 description 5
• 235000019253 formic acid Nutrition 0.000 description 5
• 239000002480 mineral oil Substances 0.000 description 5
• 235000010446 mineral oil Nutrition 0.000 description 5
• 230000035772 mutation Effects 0.000 description 5
• 229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 description 5
• 230000002285 radioactive effect Effects 0.000 description 5
• 230000009467 reduction Effects 0.000 description 5
• 210000002966 serum Anatomy 0.000 description 5
• 239000000126 substance Substances 0.000 description 5
• 208000024891 symptom Diseases 0.000 description 5
• FPGGTKZVZWFYPV-UHFFFAOYSA-M tetrabutylammonium fluoride Chemical compound [F-].CCCC[N+](CCCC)(CCCC)CCCC FPGGTKZVZWFYPV-UHFFFAOYSA-M 0.000 description 5
• ODLHGICHYURWBS-LKONHMLTSA-N trappsol cyclo Chemical compound CC(O)COC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](COCC(C)O)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](COCC(C)O)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](COCC(C)O)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](COCC(C)O)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)COCC(O)C)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1COCC(C)O ODLHGICHYURWBS-LKONHMLTSA-N 0.000 description 5
• GTLDTDOJJJZVBW-UHFFFAOYSA-N zinc cyanide Chemical compound [Zn+2].N#[C-].N#[C-] GTLDTDOJJJZVBW-UHFFFAOYSA-N 0.000 description 5
• QPFMBZIOSGYJDE-UHFFFAOYSA-N 1,1,2,2-tetrachloroethane Chemical compound ClC(Cl)C(Cl)Cl QPFMBZIOSGYJDE-UHFFFAOYSA-N 0.000 description 4
• QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 4
• NZAQRZWBQUIBSF-UHFFFAOYSA-N 4-(4-sulfobutoxy)butane-1-sulfonic acid Chemical compound OS(=O)(=O)CCCCOCCCCS(O)(=O)=O NZAQRZWBQUIBSF-UHFFFAOYSA-N 0.000 description 4
• XLSZMDLNRCVEIJ-UHFFFAOYSA-N 4-methylimidazole Chemical compound CC1=CNC=N1 XLSZMDLNRCVEIJ-UHFFFAOYSA-N 0.000 description 4
• 241000700198 Cavia Species 0.000 description 4
• KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 4
• 208000034826 Genetic Predisposition to Disease Diseases 0.000 description 4
• SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 description 4
• BZLVMXJERCGZMT-UHFFFAOYSA-N Methyl tert-butyl ether Chemical compound COC(C)(C)C BZLVMXJERCGZMT-UHFFFAOYSA-N 0.000 description 4
• 241000699666 Mus <mouse, genus> Species 0.000 description 4
• PCLIMKBDDGJMGD-UHFFFAOYSA-N N-bromosuccinimide Chemical compound BrN1C(=O)CCC1=O PCLIMKBDDGJMGD-UHFFFAOYSA-N 0.000 description 4
• MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 4
• 102000003992 Peroxidases Human genes 0.000 description 4
• WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 4
• JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 4
• 241000283984 Rodentia Species 0.000 description 4
• CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 4
• WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 description 4
• QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 4
• 230000001154 acute effect Effects 0.000 description 4
• 238000010171 animal model Methods 0.000 description 4
• 230000003190 augmentative effect Effects 0.000 description 4
• 235000011175 beta-cyclodextrine Nutrition 0.000 description 4
• 238000010256 biochemical assay Methods 0.000 description 4
• 235000011089 carbon dioxide Nutrition 0.000 description 4
• PFKFTWBEEFSNDU-UHFFFAOYSA-N carbonyldiimidazole Chemical compound C1=CN=CN1C(=O)N1C=CN=C1 PFKFTWBEEFSNDU-UHFFFAOYSA-N 0.000 description 4
• 210000001638 cerebellum Anatomy 0.000 description 4
• 238000001816 cooling Methods 0.000 description 4
• 230000009089 cytolysis Effects 0.000 description 4
• 238000010790 dilution Methods 0.000 description 4
• 239000012895 dilution Substances 0.000 description 4
• 238000009472 formulation Methods 0.000 description 4
• 125000000524 functional group Chemical group 0.000 description 4
• 239000007789 gas Substances 0.000 description 4
• 229910052736 halogen Inorganic materials 0.000 description 4
• 238000004128 high performance liquid chromatography Methods 0.000 description 4
• 238000011534 incubation Methods 0.000 description 4
• 238000004811 liquid chromatography Methods 0.000 description 4
• 239000011159 matrix material Substances 0.000 description 4
• 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 4
• 230000003287 optical effect Effects 0.000 description 4
• CTSLXHKWHWQRSH-UHFFFAOYSA-N oxalyl chloride Chemical compound ClC(=O)C(Cl)=O CTSLXHKWHWQRSH-UHFFFAOYSA-N 0.000 description 4
• KJIFKLIQANRMOU-UHFFFAOYSA-N oxidanium;4-methylbenzenesulfonate Chemical compound O.CC1=CC=C(S(O)(=O)=O)C=C1 KJIFKLIQANRMOU-UHFFFAOYSA-N 0.000 description 4
• 239000000137 peptide hydrolase inhibitor Substances 0.000 description 4
• 108040007629 peroxidase activity proteins Proteins 0.000 description 4
• IVDFJHOHABJVEH-UHFFFAOYSA-N pinacol Chemical compound CC(C)(O)C(C)(C)O IVDFJHOHABJVEH-UHFFFAOYSA-N 0.000 description 4
• SCVFZCLFOSHCOH-UHFFFAOYSA-M potassium acetate Chemical compound [K+].CC([O-])=O SCVFZCLFOSHCOH-UHFFFAOYSA-M 0.000 description 4
• WGYKZJWCGVVSQN-UHFFFAOYSA-N propylamine Chemical compound CCCN WGYKZJWCGVVSQN-UHFFFAOYSA-N 0.000 description 4
• 235000018102 proteins Nutrition 0.000 description 4
• 102000004169 proteins and genes Human genes 0.000 description 4
• 238000011002 quantification Methods 0.000 description 4
• 238000004445 quantitative analysis Methods 0.000 description 4
• 230000002829 reductive effect Effects 0.000 description 4
• 210000001202 rhombencephalon Anatomy 0.000 description 4
• 210000003625 skull Anatomy 0.000 description 4
• 239000011780 sodium chloride Substances 0.000 description 4
• 235000009518 sodium iodide Nutrition 0.000 description 4
• UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 4
• KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 4
• 230000001225 therapeutic effect Effects 0.000 description 4
• 210000001519 tissue Anatomy 0.000 description 4
• 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 description 4
• LEIMLDGFXIOXMT-UHFFFAOYSA-N trimethylsilyl cyanide Chemical compound C[Si](C)(C)C#N LEIMLDGFXIOXMT-UHFFFAOYSA-N 0.000 description 4
• ONDSBJMLAHVLMI-UHFFFAOYSA-N trimethylsilyldiazomethane Chemical compound C[Si](C)(C)[CH-][N+]#N ONDSBJMLAHVLMI-UHFFFAOYSA-N 0.000 description 4
• UAYWVJHJZHQCIE-UHFFFAOYSA-L zinc iodide Chemical compound I[Zn]I UAYWVJHJZHQCIE-UHFFFAOYSA-L 0.000 description 4
• BPXKZEMBEZGUAH-UHFFFAOYSA-N 2-(chloromethoxy)ethyl-trimethylsilane Chemical compound C[Si](C)(C)CCOCCl BPXKZEMBEZGUAH-UHFFFAOYSA-N 0.000 description 3
• IUVCFHHAEHNCFT-INIZCTEOSA-N 2-[(1s)-1-[4-amino-3-(3-fluoro-4-propan-2-yloxyphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]ethyl]-6-fluoro-3-(3-fluorophenyl)chromen-4-one Chemical compound C1=C(F)C(OC(C)C)=CC=C1C(C1=C(N)N=CN=C11)=NN1[C@@H](C)C1=C(C=2C=C(F)C=CC=2)C(=O)C2=CC(F)=CC=C2O1 IUVCFHHAEHNCFT-INIZCTEOSA-N 0.000 description 3
• PJTKIWAFRIDTBK-UHFFFAOYSA-N 2-[8-(2-chloro-6-fluorophenyl)-6,8-dihydro-5h-imidazo[2,1-c][1,4]oxazin-2-yl]-4-methoxy-1h-indole-5-carbonitrile Chemical compound C=1C=2C(OC)=C(C#N)C=CC=2NC=1C(N=C12)=CN1CCOC2C1=C(F)C=CC=C1Cl PJTKIWAFRIDTBK-UHFFFAOYSA-N 0.000 description 3
• OIYCIRNETFXUBG-UHFFFAOYSA-N 2-[8-(2-chlorophenyl)-6,8-dihydro-5H-[1,2,4]triazolo[5,1-c][1,4]oxazin-2-yl]-4-methoxy-1H-indole-5-carbonitrile Chemical compound C=1C=2C(OC)=C(C#N)C=CC=2NC=1C(=NN1CCO2)N=C1C2C1=CC=CC=C1Cl OIYCIRNETFXUBG-UHFFFAOYSA-N 0.000 description 3
• CHLUUWQLDURKRV-UHFFFAOYSA-N 2-[8-(2-chlorophenyl)-6,8-dihydro-5h-imidazo[2,1-c][1,4]oxazin-2-yl]-4-methoxy-1h-indole-5-carbonitrile Chemical compound C=1C=2C(OC)=C(C#N)C=CC=2NC=1C(N=C12)=CN1CCOC2C1=CC=CC=C1Cl CHLUUWQLDURKRV-UHFFFAOYSA-N 0.000 description 3
• MSAAIINVKIJDRK-UHFFFAOYSA-N 2-[8-(2-fluoro-6-methylphenyl)-6,8-dihydro-5H-[1,2,4]triazolo[5,1-c][1,4]oxazin-2-yl]-4-methoxy-1H-indole-5-carbonitrile Chemical compound C=1C=2C(OC)=C(C#N)C=CC=2NC=1C(=NN1CCO2)N=C1C2C1=C(C)C=CC=C1F MSAAIINVKIJDRK-UHFFFAOYSA-N 0.000 description 3
• HKQJKTOVXPJOIC-UHFFFAOYSA-N 2-[8-(2-fluoro-6-methylphenyl)-6,8-dihydro-5h-imidazo[2,1-c][1,4]oxazin-2-yl]-4-methoxy-1h-indole-5-carbonitrile Chemical compound C=1C=2C(OC)=C(C#N)C=CC=2NC=1C(N=C12)=CN1CCOC2C1=C(C)C=CC=C1F HKQJKTOVXPJOIC-UHFFFAOYSA-N 0.000 description 3
• WPNPRHCJKGFQQR-UHFFFAOYSA-N 2-[8-(2-methylphenyl)-5,6,7,8-tetrahydro-[1,2,4]triazolo[1,5-a]pyridin-2-yl]-1H-indole-5-carbonitrile Chemical compound CC1=CC=CC=C1C1C2=NC(C=3NC4=CC=C(C=C4C=3)C#N)=NN2CCC1 WPNPRHCJKGFQQR-UHFFFAOYSA-N 0.000 description 3
• WFEYOSSOODGTTR-UHFFFAOYSA-N 2-[8-(3-chloro-4-fluorophenyl)-6,8-dihydro-5H-[1,2,4]triazolo[5,1-c][1,4]oxazin-2-yl]-4-methoxy-1H-indole-5-carbonitrile Chemical compound C=1C=2C(OC)=C(C#N)C=CC=2NC=1C(=NN1CCO2)N=C1C2C1=CC=C(F)C(Cl)=C1 WFEYOSSOODGTTR-UHFFFAOYSA-N 0.000 description 3
• FDLPDFZJOWGTFN-UHFFFAOYSA-N 2-[8-(3-fluoro-2-methylphenyl)-6,8-dihydro-5H-[1,2,4]triazolo[5,1-c][1,4]oxazin-2-yl]-4-methoxy-1H-indole-5-carbonitrile Chemical compound C=1C=2C(OC)=C(C#N)C=CC=2NC=1C(=NN1CCO2)N=C1C2C1=CC=CC(F)=C1C FDLPDFZJOWGTFN-UHFFFAOYSA-N 0.000 description 3
• UBJJQXXWGRHIDV-UHFFFAOYSA-N 2-[8-(3-fluoro-2-methylphenyl)-6,8-dihydro-5h-imidazo[2,1-c][1,4]oxazin-2-yl]-4-methoxy-1h-indole-5-carbonitrile Chemical compound C=1C=2C(OC)=C(C#N)C=CC=2NC=1C(N=C12)=CN1CCOC2C1=CC=CC(F)=C1C UBJJQXXWGRHIDV-UHFFFAOYSA-N 0.000 description 3
• HFHNXNIBUZIRMD-UHFFFAOYSA-N 2-[8-(4-fluoro-2-methylphenyl)-5,6,7,8-tetrahydro-[1,2,4]triazolo[1,5-a]pyridin-2-yl]-1H-indole-5-carbonitrile Chemical compound CC1=CC(F)=CC=C1C1C2=NC(C=3NC4=CC=C(C=C4C=3)C#N)=NN2CCC1 HFHNXNIBUZIRMD-UHFFFAOYSA-N 0.000 description 3
• HHCGLAKEPAITEV-UHFFFAOYSA-N 2-[8-(4-fluoro-2-methylphenyl)-5,6,7,8-tetrahydroimidazo[1,2-a]pyridin-2-yl]-1h-indole-5-carbonitrile Chemical compound CC1=CC(F)=CC=C1C1C2=NC(C=3NC4=CC=C(C=C4C=3)C#N)=CN2CCC1 HHCGLAKEPAITEV-UHFFFAOYSA-N 0.000 description 3
• XYQDAYZDRBKPNR-UHFFFAOYSA-N 2-[8-(4-fluoro-2-methylphenyl)-6,8-dihydro-5H-[1,2,4]triazolo[5,1-c][1,4]oxazin-2-yl]-4-methoxy-1H-indole-5-carbonitrile Chemical compound C=1C=2C(OC)=C(C#N)C=CC=2NC=1C(=NN1CCO2)N=C1C2C1=CC=C(F)C=C1C XYQDAYZDRBKPNR-UHFFFAOYSA-N 0.000 description 3
• HVSDODQLRPYGML-UHFFFAOYSA-N 2-[8-(4-fluoro-2-methylphenyl)-6,8-dihydro-5h-imidazo[2,1-c][1,4]oxazin-2-yl]-4-methoxy-1h-indole-5-carbonitrile Chemical compound C=1C=2C(OC)=C(C#N)C=CC=2NC=1C(N=C12)=CN1CCOC2C1=CC=C(F)C=C1C HVSDODQLRPYGML-UHFFFAOYSA-N 0.000 description 3
• FCIUWUZLIGGKJJ-UHFFFAOYSA-N 2-[8-(5-fluoro-2-methylphenyl)-6,8-dihydro-5h-imidazo[2,1-c][1,4]oxazin-2-yl]-4-methoxy-1h-indole-5-carbonitrile Chemical compound C=1C=2C(OC)=C(C#N)C=CC=2NC=1C(N=C12)=CN1CCOC2C1=CC(F)=CC=C1C FCIUWUZLIGGKJJ-UHFFFAOYSA-N 0.000 description 3
• BTPYYDSSAJFREI-UHFFFAOYSA-N 2-[8-[2-fluoro-5-(trifluoromethyl)phenyl]-6,8-dihydro-5H-[1,2,4]triazolo[5,1-c][1,4]oxazin-2-yl]-4-methoxy-1H-indole-5-carbonitrile Chemical compound C=1C=2C(OC)=C(C#N)C=CC=2NC=1C(=NN1CCO2)N=C1C2C1=CC(C(F)(F)F)=CC=C1F BTPYYDSSAJFREI-UHFFFAOYSA-N 0.000 description 3
• IDRDJUXJJABPLN-UHFFFAOYSA-N 2-[8-[2-fluoro-5-(trifluoromethyl)phenyl]-6,8-dihydro-5h-imidazo[2,1-c][1,4]oxazin-2-yl]-4-methoxy-1h-indole-5-carbonitrile Chemical compound C=1C=2C(OC)=C(C#N)C=CC=2NC=1C(N=C12)=CN1CCOC2C1=CC(C(F)(F)F)=CC=C1F IDRDJUXJJABPLN-UHFFFAOYSA-N 0.000 description 3
• LCOGIXDREWIOKS-UHFFFAOYSA-N 2-[8-[2-fluoro-6-(trifluoromethyl)phenyl]-6,8-dihydro-5H-[1,2,4]triazolo[5,1-c][1,4]oxazin-2-yl]-4-methoxy-1H-indole-5-carbonitrile Chemical compound C=1C=2C(OC)=C(C#N)C=CC=2NC=1C(=NN1CCO2)N=C1C2C1=C(F)C=CC=C1C(F)(F)F LCOGIXDREWIOKS-UHFFFAOYSA-N 0.000 description 3
• AOISQQKLSIPOKV-UHFFFAOYSA-N 2-[8-[2-fluoro-6-(trifluoromethyl)phenyl]-6,8-dihydro-5h-imidazo[2,1-c][1,4]oxazin-2-yl]-4-methoxy-1h-indole-5-carbonitrile Chemical compound C=1C=2C(OC)=C(C#N)C=CC=2NC=1C(N=C12)=CN1CCOC2C1=C(F)C=CC=C1C(F)(F)F AOISQQKLSIPOKV-UHFFFAOYSA-N 0.000 description 3
• BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 3
• SAQUBHTVOXVVGH-UHFFFAOYSA-N 3-fluoro-2-[8-(4-fluoro-2-methylphenyl)-5,6,7,8-tetrahydro-[1,2,4]triazolo[1,5-a]pyridin-2-yl]-1H-indole-5-carbonitrile Chemical compound CC1=CC(F)=CC=C1C1C2=NC(C3=C(C4=CC(=CC=C4N3)C#N)F)=NN2CCC1 SAQUBHTVOXVVGH-UHFFFAOYSA-N 0.000 description 3
• ADCFIKGEGWFWEA-UHFFFAOYSA-N 4-fluoro-2-methylbenzaldehyde Chemical compound CC1=CC(F)=CC=C1C=O ADCFIKGEGWFWEA-UHFFFAOYSA-N 0.000 description 3
• OTCNEYHBKYYZGC-UHFFFAOYSA-N 4-methoxy-2-[8-[2-(methoxymethyl)phenyl]-5,6,7,8-tetrahydro-[1,2,4]triazolo[1,5-a]pyridin-2-yl]-1H-indole-5-carbonitrile Chemical compound COCC1=CC=CC=C1C1C2=NC(C=3NC4=CC=C(C(OC)=C4C=3)C#N)=NN2CCC1 OTCNEYHBKYYZGC-UHFFFAOYSA-N 0.000 description 3
• PKLALEKIGAUIEA-UHFFFAOYSA-N 4-methoxy-2-[8-[2-(methoxymethyl)phenyl]-6,8-dihydro-5h-imidazo[2,1-c][1,4]oxazin-2-yl]-1h-indole-5-carbonitrile Chemical compound COCC1=CC=CC=C1C1C2=NC(C=3NC4=CC=C(C(OC)=C4C=3)C#N)=CN2CCO1 PKLALEKIGAUIEA-UHFFFAOYSA-N 0.000 description 3
• ZOVFQRDNBWHWDZ-UHFFFAOYSA-N 4-methoxy-2-[8-[2-(trifluoromethyl)phenyl]-6,8-dihydro-5h-imidazo[2,1-c][1,4]oxazin-2-yl]-1h-indole-5-carbonitrile Chemical compound C=1C=2C(OC)=C(C#N)C=CC=2NC=1C(N=C12)=CN1CCOC2C1=CC=CC=C1C(F)(F)F ZOVFQRDNBWHWDZ-UHFFFAOYSA-N 0.000 description 3
• SWVQFTATJKGKJI-UHFFFAOYSA-N 4-methoxy-2-[8-[5-methyl-2-(2,2,2-trifluoroethyl)pyrazol-3-yl]-5,6,7,8-tetrahydroimidazo[1,2-a]pyridin-2-yl]-1h-indole-5-carbonitrile Chemical compound C=1C=2C(OC)=C(C#N)C=CC=2NC=1C(N=C12)=CN1CCCC2C1=CC(C)=NN1CC(F)(F)F SWVQFTATJKGKJI-UHFFFAOYSA-N 0.000 description 3
• XFJBGINZIMNZBW-CRAIPNDOSA-N 5-chloro-2-[4-[(1r,2s)-2-[2-(5-methylsulfonylpyridin-2-yl)oxyethyl]cyclopropyl]piperidin-1-yl]pyrimidine Chemical compound N1=CC(S(=O)(=O)C)=CC=C1OCC[C@H]1[C@@H](C2CCN(CC2)C=2N=CC(Cl)=CN=2)C1 XFJBGINZIMNZBW-CRAIPNDOSA-N 0.000 description 3
• TUPGKMCVPDIALA-UHFFFAOYSA-N 8-(4-fluoro-2-methylphenyl)-2-[5-(1-methylpyrazol-4-yl)-1H-pyrrolo[3,2-b]pyridin-2-yl]-5,6,7,8-tetrahydro-[1,2,4]triazolo[1,5-a]pyridine Chemical compound CC1=CC(F)=CC=C1C1C2=NC(C=3NC4=CC=C(N=C4C=3)C3=CN(C)N=C3)=NN2CCC1 TUPGKMCVPDIALA-UHFFFAOYSA-N 0.000 description 3
• XOXCMLLOPANMLC-UHFFFAOYSA-N 8-(4-fluoro-2-methylphenyl)-2-[5-(4-methylimidazol-1-yl)-1H-indol-2-yl]-5,6,7,8-tetrahydro-[1,2,4]triazolo[1,5-a]pyridine Chemical compound C1=NC(C)=CN1C1=CC=C(NC(=C2)C3=NN4CCCC(C4=N3)C=3C(=CC(F)=CC=3)C)C2=C1 XOXCMLLOPANMLC-UHFFFAOYSA-N 0.000 description 3
• ZFXSQUOLDJWQAV-UHFFFAOYSA-N 8-(4-fluoro-2-methylphenyl)-2-[5-(4-methylimidazol-1-yl)-1H-indol-2-yl]-6,8-dihydro-5H-[1,2,4]triazolo[5,1-c][1,4]oxazine Chemical compound C1=NC(C)=CN1C1=CC=C(NC(=C2)C3=NN4CCOC(C4=N3)C=3C(=CC(F)=CC=3)C)C2=C1 ZFXSQUOLDJWQAV-UHFFFAOYSA-N 0.000 description 3
• RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 3
• IAZDPXIOMUYVGZ-WFGJKAKNSA-N Dimethyl sulfoxide Chemical compound [2H]C([2H])([2H])S(=O)C([2H])([2H])[2H] IAZDPXIOMUYVGZ-WFGJKAKNSA-N 0.000 description 3
• LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
• CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 3
• XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 3
• OFOBLEOULBTSOW-UHFFFAOYSA-N Malonic acid Chemical compound OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 3
• FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 description 3
• CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 3
• 101150003085 Pdcl gene Proteins 0.000 description 3
• DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
• RWRDLPDLKQPQOW-UHFFFAOYSA-N Pyrrolidine Chemical compound C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 description 3
• HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 3
• IOSLINNLJFQMFF-XMMPIXPASA-N [(2R)-1-[[4-[[3-[(4-fluorophenyl)methylsulfanyl]phenoxy]methyl]phenyl]methyl]pyrrolidin-2-yl]methanol Chemical compound FC1=CC=C(CSC=2C=C(OCC3=CC=C(CN4[C@H](CCC4)CO)C=C3)C=CC=2)C=C1 IOSLINNLJFQMFF-XMMPIXPASA-N 0.000 description 3
• 230000002378 acidificating effect Effects 0.000 description 3
• 229910021529 ammonia Inorganic materials 0.000 description 3
• 239000008346 aqueous phase Substances 0.000 description 3
• 230000003416 augmentation Effects 0.000 description 3
• ZADPBFCGQRWHPN-UHFFFAOYSA-N boronic acid Chemical compound OBO ZADPBFCGQRWHPN-UHFFFAOYSA-N 0.000 description 3
• 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 3
• 239000003054 catalyst Substances 0.000 description 3
• 230000003197 catalytic effect Effects 0.000 description 3
• 238000006555 catalytic reaction Methods 0.000 description 3
• KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
• 238000003776 cleavage reaction Methods 0.000 description 3
• 229940125900 compound 59 Drugs 0.000 description 3
• 238000009833 condensation Methods 0.000 description 3
• 230000005494 condensation Effects 0.000 description 3
• 238000007333 cyanation reaction Methods 0.000 description 3
• 229940079593 drug Drugs 0.000 description 3
• XWRLQRLQUKZEEU-UHFFFAOYSA-N ethyl(hydroxy)silicon Chemical class CC[Si]O XWRLQRLQUKZEEU-UHFFFAOYSA-N 0.000 description 3
• 239000012634 fragment Substances 0.000 description 3
• 239000012458 free base Substances 0.000 description 3
• 125000001072 heteroaryl group Chemical group 0.000 description 3
• 150000003840 hydrochlorides Chemical class 0.000 description 3
• 239000004615 ingredient Substances 0.000 description 3
• 230000005764 inhibitory process Effects 0.000 description 3
• UEXQBEVWFZKHNB-UHFFFAOYSA-N intermediate 29 Natural products C1=CC(N)=CC=C1NC1=NC=CC=N1 UEXQBEVWFZKHNB-UHFFFAOYSA-N 0.000 description 3
• 238000001819 mass spectrum Methods 0.000 description 3
• QARBMVPHQWIHKH-UHFFFAOYSA-N methanesulfonyl chloride Chemical compound CS(Cl)(=O)=O QARBMVPHQWIHKH-UHFFFAOYSA-N 0.000 description 3
• 239000006199 nebulizer Substances 0.000 description 3
• NNFCIKHAZHQZJG-UHFFFAOYSA-N potassium cyanide Chemical compound [K+].N#[C-] NNFCIKHAZHQZJG-UHFFFAOYSA-N 0.000 description 3
• 238000002953 preparative HPLC Methods 0.000 description 3
• 230000008569 process Effects 0.000 description 3
• 102000004196 processed proteins & peptides Human genes 0.000 description 3
• 238000010791 quenching Methods 0.000 description 3
• 102000005962 receptors Human genes 0.000 description 3
• 230000007017 scission Effects 0.000 description 3
• 238000012216 screening Methods 0.000 description 3
• 238000002560 therapeutic procedure Methods 0.000 description 3
• FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 3
• 239000003981 vehicle Substances 0.000 description 3
• 239000008096 xylene Substances 0.000 description 3
• UFYBTLOLWSABAU-UHFFFAOYSA-N (2-methylpyridin-4-yl)boronic acid Chemical compound CC1=CC(B(O)O)=CC=N1 UFYBTLOLWSABAU-UHFFFAOYSA-N 0.000 description 2
• GHYOCDFICYLMRF-UTIIJYGPSA-N (2S,3R)-N-[(2S)-3-(cyclopenten-1-yl)-1-[(2R)-2-methyloxiran-2-yl]-1-oxopropan-2-yl]-3-hydroxy-3-(4-methoxyphenyl)-2-[[(2S)-2-[(2-morpholin-4-ylacetyl)amino]propanoyl]amino]propanamide Chemical compound C1(=CCCC1)C[C@@H](C(=O)[C@@]1(OC1)C)NC([C@H]([C@@H](C1=CC=C(C=C1)OC)O)NC([C@H](C)NC(CN1CCOCC1)=O)=O)=O GHYOCDFICYLMRF-UTIIJYGPSA-N 0.000 description 2
• QFLWZFQWSBQYPS-AWRAUJHKSA-N (3S)-3-[[(2S)-2-[[(2S)-2-[5-[(3aS,6aR)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]pentanoylamino]-3-methylbutanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-4-[1-bis(4-chlorophenoxy)phosphorylbutylamino]-4-oxobutanoic acid Chemical compound CCCC(NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)CCCCC1SC[C@@H]2NC(=O)N[C@H]12)C(C)C)P(=O)(Oc1ccc(Cl)cc1)Oc1ccc(Cl)cc1 QFLWZFQWSBQYPS-AWRAUJHKSA-N 0.000 description 2
• YQOLEILXOBUDMU-KRWDZBQOSA-N (4R)-5-[(6-bromo-3-methyl-2-pyrrolidin-1-ylquinoline-4-carbonyl)amino]-4-(2-chlorophenyl)pentanoic acid Chemical compound CC1=C(C2=C(C=CC(=C2)Br)N=C1N3CCCC3)C(=O)NC[C@H](CCC(=O)O)C4=CC=CC=C4Cl YQOLEILXOBUDMU-KRWDZBQOSA-N 0.000 description 2
• RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 2
• YHYLDEVWYOFIJK-UHFFFAOYSA-N 1h-indole-5-carbonitrile Chemical compound N#CC1=CC=C2NC=CC2=C1 YHYLDEVWYOFIJK-UHFFFAOYSA-N 0.000 description 2
• YWVMKEDQCRYQHH-UHFFFAOYSA-N 2-[5-(2-methylpyridin-4-yl)-1H-indol-2-yl]-8-[2-(trifluoromethyl)phenyl]-5,6,7,8-tetrahydro-[1,2,4]triazolo[1,5-a]pyridine Chemical compound C1=NC(C)=CC(C=2C=C3C=C(NC3=CC=2)C2=NN3CCCC(C3=N2)C=2C(=CC=CC=2)C(F)(F)F)=C1 YWVMKEDQCRYQHH-UHFFFAOYSA-N 0.000 description 2
• HKIVSISKULYZKI-UHFFFAOYSA-N 2-[5-(4-methylimidazol-1-yl)-1H-indol-2-yl]-8-[2-(trifluoromethyl)phenyl]-5,6,7,8-tetrahydro-[1,2,4]triazolo[1,5-a]pyridine Chemical compound C1=NC(C)=CN1C1=CC=C(NC(=C2)C3=NN4CCCC(C4=N3)C=3C(=CC=CC=3)C(F)(F)F)C2=C1 HKIVSISKULYZKI-UHFFFAOYSA-N 0.000 description 2
• QNTRQZYLJCEOQB-UHFFFAOYSA-N 2-[5-(4-methylimidazol-1-yl)-1H-indol-2-yl]-8-[2-(trifluoromethyl)phenyl]-6,8-dihydro-5H-[1,2,4]triazolo[5,1-c][1,4]oxazine Chemical compound C1=NC(C)=CN1C1=CC=C(NC(=C2)C3=NN4CCOC(C4=N3)C=3C(=CC=CC=3)C(F)(F)F)C2=C1 QNTRQZYLJCEOQB-UHFFFAOYSA-N 0.000 description 2
• DQDFGZVLYHFLBT-UHFFFAOYSA-N 2-[5-(4-methylimidazol-1-yl)-1H-pyrrolo[3,2-b]pyridin-2-yl]-8-(2-methylphenyl)-5,6,7,8-tetrahydro-[1,2,4]triazolo[1,5-a]pyridine Chemical compound C1=NC(C)=CN1C1=CC=C(NC(=C2)C3=NN4CCCC(C4=N3)C=3C(=CC=CC=3)C)C2=N1 DQDFGZVLYHFLBT-UHFFFAOYSA-N 0.000 description 2
• GVCNSJONPNQBSI-UHFFFAOYSA-N 2-[8-(2-chloro-6-fluorophenyl)-6,8-dihydro-5H-[1,2,4]triazolo[5,1-c][1,4]oxazin-2-yl]-4-methoxy-1H-indole-5-carbonitrile Chemical compound C=1C=2C(OC)=C(C#N)C=CC=2NC=1C(=NN1CCO2)N=C1C2C1=C(F)C=CC=C1Cl GVCNSJONPNQBSI-UHFFFAOYSA-N 0.000 description 2
• GBSOHYCGLHCHCE-UHFFFAOYSA-N 2-[8-(2-chlorophenyl)-5,6,7,8-tetrahydroimidazo[1,2-a]pyridin-2-yl]-1h-indole-5-carbonitrile Chemical compound ClC1=CC=CC=C1C1C2=NC(C=3NC4=CC=C(C=C4C=3)C#N)=CN2CCC1 GBSOHYCGLHCHCE-UHFFFAOYSA-N 0.000 description 2
• PIAWXNKEFFYUCD-UHFFFAOYSA-N 2-[8-(2-cyclopropylphenyl)-6,8-dihydro-5h-imidazo[2,1-c][1,4]oxazin-2-yl]-4-methoxy-1h-indole-5-carbonitrile Chemical compound C=1C=2C(OC)=C(C#N)C=CC=2NC=1C(N=C12)=CN1CCOC2C1=CC=CC=C1C1CC1 PIAWXNKEFFYUCD-UHFFFAOYSA-N 0.000 description 2
• DMFLSYVRKZRNQA-UHFFFAOYSA-N 2-[8-(2-fluoro-3-methylphenyl)-6,8-dihydro-5H-[1,2,4]triazolo[5,1-c][1,4]oxazin-2-yl]-4-methoxy-1H-indole-5-carbonitrile Chemical compound C=1C=2C(OC)=C(C#N)C=CC=2NC=1C(=NN1CCO2)N=C1C2C1=CC=CC(C)=C1F DMFLSYVRKZRNQA-UHFFFAOYSA-N 0.000 description 2
• NRRPTURAGONJGM-UHFFFAOYSA-N 2-[8-(2-fluoro-3-methylphenyl)-6,8-dihydro-5h-imidazo[2,1-c][1,4]oxazin-2-yl]-4-methoxy-1h-indole-5-carbonitrile Chemical compound C=1C=2C(OC)=C(C#N)C=CC=2NC=1C(N=C12)=CN1CCOC2C1=CC=CC(C)=C1F NRRPTURAGONJGM-UHFFFAOYSA-N 0.000 description 2
• SEICVBPPQDZYEM-UHFFFAOYSA-N 2-[8-(3-chloro-4-fluorophenyl)-6,8-dihydro-5h-imidazo[2,1-c][1,4]oxazin-2-yl]-4-methoxy-1h-indole-5-carbonitrile Chemical compound C=1C=2C(OC)=C(C#N)C=CC=2NC=1C(N=C12)=CN1CCOC2C1=CC=C(F)C(Cl)=C1 SEICVBPPQDZYEM-UHFFFAOYSA-N 0.000 description 2
• VCYWYCQVZYLCKS-UHFFFAOYSA-N 2-[8-(4-fluoro-2-methylphenyl)-5,6,7,8-tetrahydroimidazo[1,2-a]pyridin-2-yl]-5-(1-methylpyrazol-4-yl)-1h-pyrrolo[3,2-b]pyridine Chemical compound CC1=CC(F)=CC=C1C1C2=NC(C=3NC4=CC=C(N=C4C=3)C3=CN(C)N=C3)=CN2CCC1 VCYWYCQVZYLCKS-UHFFFAOYSA-N 0.000 description 2
• PNNWNAQAFSGRAV-UHFFFAOYSA-N 2-[8-(4-fluoro-2-methylphenyl)-6,8-dihydro-5H-[1,2,4]triazolo[5,1-c][1,4]oxazin-2-yl]-1H-indole-5-carbonitrile Chemical compound CC1=CC(F)=CC=C1C1C2=NC(C=3NC4=CC=C(C=C4C=3)C#N)=NN2CCO1 PNNWNAQAFSGRAV-UHFFFAOYSA-N 0.000 description 2
• SZEGPWGYEXLJPG-UHFFFAOYSA-N 2-[8-[3-fluoro-2-(trifluoromethyl)phenyl]-6,8-dihydro-5h-imidazo[2,1-c][1,4]oxazin-2-yl]-4-methoxy-1h-indole-5-carbonitrile Chemical compound C=1C=2C(OC)=C(C#N)C=CC=2NC=1C(N=C12)=CN1CCOC2C1=CC=CC(F)=C1C(F)(F)F SZEGPWGYEXLJPG-UHFFFAOYSA-N 0.000 description 2
• ICSNLGPSRYBMBD-UHFFFAOYSA-N 2-aminopyridine Chemical compound NC1=CC=CC=N1 ICSNLGPSRYBMBD-UHFFFAOYSA-N 0.000 description 2
• 125000004105 2-pyridyl group Chemical group N1=C([*])C([H])=C([H])C([H])=C1[H] 0.000 description 2
• BGAJNPLDJJBRHK-UHFFFAOYSA-N 3-[2-[5-(3-chloro-4-propan-2-yloxyphenyl)-1,3,4-thiadiazol-2-yl]-3-methyl-6,7-dihydro-4h-pyrazolo[4,3-c]pyridin-5-yl]propanoic acid Chemical compound C1=C(Cl)C(OC(C)C)=CC=C1C1=NN=C(N2C(=C3CN(CCC(O)=O)CCC3=N2)C)S1 BGAJNPLDJJBRHK-UHFFFAOYSA-N 0.000 description 2
• HSUCYMJBFHBMTB-UHFFFAOYSA-N 3-fluoro-2-methylbenzaldehyde Chemical compound CC1=C(F)C=CC=C1C=O HSUCYMJBFHBMTB-UHFFFAOYSA-N 0.000 description 2
• WYFCZWSWFGJODV-MIANJLSGSA-N 4-[[(1s)-2-[(e)-3-[3-chloro-2-fluoro-6-(tetrazol-1-yl)phenyl]prop-2-enoyl]-5-(4-methyl-2-oxopiperazin-1-yl)-3,4-dihydro-1h-isoquinoline-1-carbonyl]amino]benzoic acid Chemical compound O=C1CN(C)CCN1C1=CC=CC2=C1CCN(C(=O)\C=C\C=1C(=CC=C(Cl)C=1F)N1N=NN=C1)[C@@H]2C(=O)NC1=CC=C(C(O)=O)C=C1 WYFCZWSWFGJODV-MIANJLSGSA-N 0.000 description 2
• NFZWXCQYERVPEI-UHFFFAOYSA-N 4-methoxy-2-[8-[2-(trifluoromethyl)phenyl]-6,8-dihydro-5H-[1,2,4]triazolo[5,1-c][1,4]oxazin-2-yl]-1H-indole-5-carbonitrile Chemical compound C=1C=2C(OC)=C(C#N)C=CC=2NC=1C(=NN1CCO2)N=C1C2C1=CC=CC=C1C(F)(F)F NFZWXCQYERVPEI-UHFFFAOYSA-N 0.000 description 2
• GHSRMSJVYMITDX-UHFFFAOYSA-N 6-chloro-2-methyl-3-nitropyridine Chemical compound CC1=NC(Cl)=CC=C1[N+]([O-])=O GHSRMSJVYMITDX-UHFFFAOYSA-N 0.000 description 2
• VQLPLKONRWZLKZ-UHFFFAOYSA-N 8-(2-methoxyphenyl)-2-[5-(4-methylimidazol-1-yl)-1H-indol-2-yl]-5,6,7,8-tetrahydro-[1,2,4]triazolo[1,5-a]pyridine Chemical compound COC1=CC=CC=C1C1C2=NC(C=3NC4=CC=C(C=C4C=3)N3C=C(C)N=C3)=NN2CCC1 VQLPLKONRWZLKZ-UHFFFAOYSA-N 0.000 description 2
• ZVELEQBJSARRIA-UHFFFAOYSA-N 8-(4-fluoro-2-methylphenyl)-2-[4-methoxy-5-(4-methylimidazol-1-yl)-1H-indol-2-yl]-5,6,7,8-tetrahydro-[1,2,4]triazolo[1,5-a]pyridine Chemical compound C=1C=2C(OC)=C(N3C=C(C)N=C3)C=CC=2NC=1C(=NN1CCC2)N=C1C2C1=CC=C(F)C=C1C ZVELEQBJSARRIA-UHFFFAOYSA-N 0.000 description 2
• QKQLKODLLXWAJM-UHFFFAOYSA-N 8-(4-fluoro-2-methylphenyl)-2-[4-methoxy-5-(4-methylimidazol-1-yl)-1h-indol-2-yl]-5,6,7,8-tetrahydroimidazo[1,2-a]pyridine Chemical compound C=1C=2C(OC)=C(N3C=C(C)N=C3)C=CC=2NC=1C(N=C12)=CN1CCCC2C1=CC=C(F)C=C1C QKQLKODLLXWAJM-UHFFFAOYSA-N 0.000 description 2
• UXDLZSWWXZGFFL-UHFFFAOYSA-N 8-(4-fluoro-2-methylphenyl)-2-[4-methoxy-5-(4-methylimidazol-1-yl)-1h-indol-2-yl]-6,8-dihydro-5h-imidazo[2,1-c][1,4]oxazine Chemical compound C=1C=2C(OC)=C(N3C=C(C)N=C3)C=CC=2NC=1C(N=C12)=CN1CCOC2C1=CC=C(F)C=C1C UXDLZSWWXZGFFL-UHFFFAOYSA-N 0.000 description 2
• MRTZVZIUHKXYDN-UHFFFAOYSA-N 8-(4-fluoro-2-methylphenyl)-2-[5-(1-methylpyrazol-4-yl)-1h-pyrrolo[3,2-b]pyridin-2-yl]-6,8-dihydro-5h-imidazo[2,1-c][1,4]oxazine Chemical compound CC1=CC(F)=CC=C1C1C2=NC(C=3NC4=CC=C(N=C4C=3)C3=CN(C)N=C3)=CN2CCO1 MRTZVZIUHKXYDN-UHFFFAOYSA-N 0.000 description 2
• ADALGTFQPOYXOB-UHFFFAOYSA-N 8-(4-fluoro-2-methylphenyl)-2-[5-(4-methylimidazol-1-yl)-1H-pyrrolo[2,3-b]pyridin-2-yl]-5,6,7,8-tetrahydro-[1,2,4]triazolo[1,5-a]pyridine Chemical compound C1=NC(C)=CN1C1=CN=C(NC(=C2)C3=NN4CCCC(C4=N3)C=3C(=CC(F)=CC=3)C)C2=C1 ADALGTFQPOYXOB-UHFFFAOYSA-N 0.000 description 2
• OGHQGYZVXUVGLY-UHFFFAOYSA-N 8-(4-fluoro-2-methylphenyl)-2-[5-(4-methylimidazol-1-yl)-1H-pyrrolo[3,2-b]pyridin-2-yl]-5,6,7,8-tetrahydro-[1,2,4]triazolo[1,5-a]pyridine Chemical compound C1=NC(C)=CN1C1=CC=C(NC(=C2)C3=NN4CCCC(C4=N3)C=3C(=CC(F)=CC=3)C)C2=N1 OGHQGYZVXUVGLY-UHFFFAOYSA-N 0.000 description 2
• GGZOIBIFSPUASP-UHFFFAOYSA-N 8-(4-fluoro-2-methylphenyl)-2-[6-(2-methylpyridin-4-yl)-1H-benzimidazol-2-yl]-5,6,7,8-tetrahydro-[1,2,4]triazolo[1,5-a]pyridine Chemical compound C1=NC(C)=CC(C=2C=C3N=C(NC3=CC=2)C2=NN3CCCC(C3=N2)C=2C(=CC(F)=CC=2)C)=C1 GGZOIBIFSPUASP-UHFFFAOYSA-N 0.000 description 2
• HWWAJUFEKCOKSC-UHFFFAOYSA-N 8-(4-fluoro-2-methylphenyl)-2-[6-(4-methylimidazol-1-yl)-1H-benzimidazol-2-yl]-5,6,7,8-tetrahydro-[1,2,4]triazolo[1,5-a]pyridine Chemical compound C1=NC(C)=CN1C1=CC=C(NC(=N2)C3=NN4CCCC(C4=N3)C=3C(=CC(F)=CC=3)C)C2=C1 HWWAJUFEKCOKSC-UHFFFAOYSA-N 0.000 description 2
• NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 2
• 208000037259 Amyloid Plaque Diseases 0.000 description 2
• 102100029470 Apolipoprotein E Human genes 0.000 description 2
• 101710095339 Apolipoprotein E Proteins 0.000 description 2
• 238000006443 Buchwald-Hartwig cross coupling reaction Methods 0.000 description 2
• HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
• 102100032373 Coiled-coil domain-containing protein 85B Human genes 0.000 description 2
• RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 2
• 229910021589 Copper(I) bromide Inorganic materials 0.000 description 2
• 102000002004 Cytochrome P-450 Enzyme System Human genes 0.000 description 2
• 108010015742 Cytochrome P-450 Enzyme System Proteins 0.000 description 2
• ROSDSFDQCJNGOL-UHFFFAOYSA-N Dimethylamine Chemical compound CNC ROSDSFDQCJNGOL-UHFFFAOYSA-N 0.000 description 2
• 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 2
• QUSNBJAOOMFDIB-UHFFFAOYSA-N Ethylamine Chemical compound CCN QUSNBJAOOMFDIB-UHFFFAOYSA-N 0.000 description 2
• VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
• WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
• AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 2
• 101000868814 Homo sapiens Coiled-coil domain-containing protein 85B Proteins 0.000 description 2
• WTDHULULXKLSOZ-UHFFFAOYSA-N Hydroxylamine hydrochloride Chemical compound Cl.ON WTDHULULXKLSOZ-UHFFFAOYSA-N 0.000 description 2
• DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
• CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
• AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 2
• BAVYZALUXZFZLV-UHFFFAOYSA-N Methylamine Chemical compound NC BAVYZALUXZFZLV-UHFFFAOYSA-N 0.000 description 2
• YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical compound C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 description 2
• 241000872931 Myoporum sandwicense Species 0.000 description 2
• LVDRREOUMKACNJ-BKMJKUGQSA-N N-[(2R,3S)-2-(4-chlorophenyl)-1-(1,4-dimethyl-2-oxoquinolin-7-yl)-6-oxopiperidin-3-yl]-2-methylpropane-1-sulfonamide Chemical compound CC(C)CS(=O)(=O)N[C@H]1CCC(=O)N([C@@H]1c1ccc(Cl)cc1)c1ccc2c(C)cc(=O)n(C)c2c1 LVDRREOUMKACNJ-BKMJKUGQSA-N 0.000 description 2
• 229930182555 Penicillin Natural products 0.000 description 2
• JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 2
• NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
• NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 2
• 102000004005 Prostaglandin-endoperoxide synthases Human genes 0.000 description 2
• 108090000459 Prostaglandin-endoperoxide synthases Proteins 0.000 description 2
• 229940124158 Protease/peptidase inhibitor Drugs 0.000 description 2
• LCTONWCANYUPML-UHFFFAOYSA-N Pyruvic acid Chemical compound CC(=O)C(O)=O LCTONWCANYUPML-UHFFFAOYSA-N 0.000 description 2
• SMWDFEZZVXVKRB-UHFFFAOYSA-N Quinoline Chemical compound N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 description 2
• UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
• 238000003477 Sonogashira cross-coupling reaction Methods 0.000 description 2
• HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 2
• SPXSEZMVRJLHQG-XMMPIXPASA-N [(2R)-1-[[4-[(3-phenylmethoxyphenoxy)methyl]phenyl]methyl]pyrrolidin-2-yl]methanol Chemical compound C(C1=CC=CC=C1)OC=1C=C(OCC2=CC=C(CN3[C@H](CCC3)CO)C=C2)C=CC=1 SPXSEZMVRJLHQG-XMMPIXPASA-N 0.000 description 2
• 239000012346 acetyl chloride Substances 0.000 description 2
• 150000007513 acids Chemical class 0.000 description 2
• 239000000654 additive Substances 0.000 description 2
• 150000001298 alcohols Chemical class 0.000 description 2
• 229910052784 alkaline earth metal Inorganic materials 0.000 description 2
• 239000002168 alkylating agent Substances 0.000 description 2
• 229940100198 alkylating agent Drugs 0.000 description 2
• 235000001014 amino acid Nutrition 0.000 description 2
• 239000012298 atmosphere Substances 0.000 description 2
• QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
• 230000008901 benefit Effects 0.000 description 2
• WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
• 230000002051 biphasic effect Effects 0.000 description 2
• ILAHWRKJUDSMFH-UHFFFAOYSA-N boron tribromide Chemical compound BrB(Br)Br ILAHWRKJUDSMFH-UHFFFAOYSA-N 0.000 description 2
• 210000003169 central nervous system Anatomy 0.000 description 2
• 229910052729 chemical element Inorganic materials 0.000 description 2
• 239000003153 chemical reaction reagent Substances 0.000 description 2
• 239000003638 chemical reducing agent Substances 0.000 description 2
• 229940125904 compound 1 Drugs 0.000 description 2
• 229940125797 compound 12 Drugs 0.000 description 2
• 229940125782 compound 2 Drugs 0.000 description 2
• 229940126214 compound 3 Drugs 0.000 description 2
• 229940125844 compound 46 Drugs 0.000 description 2
• 229940127271 compound 49 Drugs 0.000 description 2
• 229940125898 compound 5 Drugs 0.000 description 2
• 238000006482 condensation reaction Methods 0.000 description 2
• 239000010949 copper Substances 0.000 description 2
• 229910052802 copper Inorganic materials 0.000 description 2
• 125000004122 cyclic group Chemical group 0.000 description 2
• 238000013480 data collection Methods 0.000 description 2
• 230000018109 developmental process Effects 0.000 description 2
• JQVDAXLFBXTEQA-UHFFFAOYSA-N dibutylamine Chemical compound CCCCNCCCC JQVDAXLFBXTEQA-UHFFFAOYSA-N 0.000 description 2
• LVTYICIALWPMFW-UHFFFAOYSA-N diisopropanolamine Chemical compound CC(O)CNCC(C)O LVTYICIALWPMFW-UHFFFAOYSA-N 0.000 description 2
• 229940043279 diisopropylamine Drugs 0.000 description 2
• 239000003085 diluting agent Substances 0.000 description 2
• 229940042399 direct acting antivirals protease inhibitors Drugs 0.000 description 2
• 208000035475 disorder Diseases 0.000 description 2
• 238000001378 electrochemiluminescence detection Methods 0.000 description 2
• 238000005516 engineering process Methods 0.000 description 2
• 239000003623 enhancer Substances 0.000 description 2
• 239000003797 essential amino acid Substances 0.000 description 2
• 235000020776 essential amino acid Nutrition 0.000 description 2
• VZSOXWAHGVEQOT-UHFFFAOYSA-N ethyl 5-cyano-1h-indole-2-carboxylate Chemical compound N#CC1=CC=C2NC(C(=O)OCC)=CC2=C1 VZSOXWAHGVEQOT-UHFFFAOYSA-N 0.000 description 2
• 239000008103 glucose Substances 0.000 description 2
• 230000002140 halogenating effect Effects 0.000 description 2
• 150000002367 halogens Chemical class 0.000 description 2
• 125000000623 heterocyclic group Chemical group 0.000 description 2
• 239000000833 heterodimer Substances 0.000 description 2
• 150000004677 hydrates Chemical class 0.000 description 2
• 239000005457 ice water Substances 0.000 description 2
• PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Natural products CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 description 2
• RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Natural products C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 description 2
• 230000002401 inhibitory effect Effects 0.000 description 2
• 229940079865 intestinal antiinfectives imidazole derivative Drugs 0.000 description 2
• 238000002955 isolation Methods 0.000 description 2
• AWJUIBRHMBBTKR-UHFFFAOYSA-N isoquinoline Chemical compound C1=NC=CC2=CC=CC=C21 AWJUIBRHMBBTKR-UHFFFAOYSA-N 0.000 description 2
• JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
• HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
• 238000004949 mass spectrometry Methods 0.000 description 2
• 239000002609 medium Substances 0.000 description 2
• 102000046701 nicastrin Human genes 0.000 description 2
• 108700022821 nicastrin Proteins 0.000 description 2
• 231100000252 nontoxic Toxicity 0.000 description 2
• 230000003000 nontoxic effect Effects 0.000 description 2
• GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 2
• 239000002674 ointment Substances 0.000 description 2
• 150000007530 organic bases Chemical class 0.000 description 2
• 239000003960 organic solvent Substances 0.000 description 2
• 229910052760 oxygen Inorganic materials 0.000 description 2
• 239000001301 oxygen Substances 0.000 description 2
• YJVFFLUZDVXJQI-UHFFFAOYSA-L palladium(ii) acetate Chemical compound [Pd+2].CC([O-])=O.CC([O-])=O YJVFFLUZDVXJQI-UHFFFAOYSA-L 0.000 description 2
• NFHFRUOZVGFOOS-UHFFFAOYSA-N palladium;triphenylphosphane Chemical compound [Pd].C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 NFHFRUOZVGFOOS-UHFFFAOYSA-N 0.000 description 2
• 229940049954 penicillin Drugs 0.000 description 2
• 230000035699 permeability Effects 0.000 description 2
• 239000002504 physiological saline solution Substances 0.000 description 2
• 239000006187 pill Substances 0.000 description 2
• BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
• 239000001103 potassium chloride Substances 0.000 description 2
• 235000011164 potassium chloride Nutrition 0.000 description 2
• 239000000843 powder Substances 0.000 description 2
• 239000002243 precursor Substances 0.000 description 2
• VVWRJUBEIPHGQF-MDZDMXLPSA-N propan-2-yl (ne)-n-propan-2-yloxycarbonyliminocarbamate Chemical compound CC(C)OC(=O)\N=N\C(=O)OC(C)C VVWRJUBEIPHGQF-MDZDMXLPSA-N 0.000 description 2
• 230000002797 proteolythic effect Effects 0.000 description 2
• UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 2
• YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
• 238000000926 separation method Methods 0.000 description 2
• 229910052708 sodium Inorganic materials 0.000 description 2
• 229910000029 sodium carbonate Inorganic materials 0.000 description 2
• MNWBNISUBARLIT-UHFFFAOYSA-N sodium cyanide Chemical compound [Na+].N#[C-] MNWBNISUBARLIT-UHFFFAOYSA-N 0.000 description 2
• LPXPTNMVRIOKMN-UHFFFAOYSA-M sodium nitrite Chemical compound [Na+].[O-]N=O LPXPTNMVRIOKMN-UHFFFAOYSA-M 0.000 description 2
• JQWHASGSAFIOCM-UHFFFAOYSA-M sodium periodate Chemical compound [Na+].[O-]I(=O)(=O)=O JQWHASGSAFIOCM-UHFFFAOYSA-M 0.000 description 2
• 241000894007 species Species 0.000 description 2
• 230000000638 stimulation Effects 0.000 description 2
• 229960005322 streptomycin Drugs 0.000 description 2
• 229960005137 succinic acid Drugs 0.000 description 2
• 230000008685 targeting Effects 0.000 description 2
• VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
• 125000000876 trifluoromethoxy group Chemical group FC(F)(F)O* 0.000 description 2
• GETQZCLCWQTVFV-UHFFFAOYSA-N trimethylamine Chemical compound CN(C)C GETQZCLCWQTVFV-UHFFFAOYSA-N 0.000 description 2
• RIOQSEWOXXDEQQ-UHFFFAOYSA-N triphenylphosphine Chemical compound C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 RIOQSEWOXXDEQQ-UHFFFAOYSA-N 0.000 description 2
• DNIAPMSPPWPWGF-VKHMYHEASA-N (+)-propylene glycol Chemical compound C[C@H](O)CO DNIAPMSPPWPWGF-VKHMYHEASA-N 0.000 description 1
• SZUVGFMDDVSKSI-WIFOCOSTSA-N (1s,2s,3s,5r)-1-(carboxymethyl)-3,5-bis[(4-phenoxyphenyl)methyl-propylcarbamoyl]cyclopentane-1,2-dicarboxylic acid Chemical compound O=C([C@@H]1[C@@H]([C@](CC(O)=O)([C@H](C(=O)N(CCC)CC=2C=CC(OC=3C=CC=CC=3)=CC=2)C1)C(O)=O)C(O)=O)N(CCC)CC(C=C1)=CC=C1OC1=CC=CC=C1 SZUVGFMDDVSKSI-WIFOCOSTSA-N 0.000 description 1
• WMGVPDQNPUQRND-UHFFFAOYSA-N (2-methylphenyl)acetonitrile Chemical compound CC1=CC=CC=C1CC#N WMGVPDQNPUQRND-UHFFFAOYSA-N 0.000 description 1
• NBKZGRPRTQELKX-UHFFFAOYSA-N (2-methylpropan-2-yl)oxymethanone Chemical compound CC(C)(C)O[C]=O NBKZGRPRTQELKX-UHFFFAOYSA-N 0.000 description 1
• YJLIKUSWRSEPSM-WGQQHEPDSA-N (2r,3r,4s,5r)-2-[6-amino-8-[(4-phenylphenyl)methylamino]purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol Chemical compound C=1C=C(C=2C=CC=CC=2)C=CC=1CNC1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O YJLIKUSWRSEPSM-WGQQHEPDSA-N 0.000 description 1
• VIJSPAIQWVPKQZ-BLECARSGSA-N (2s)-2-[[(2s)-2-[[(2s)-2-[[(2s)-2-[[(2s)-2-[[(2s)-2-acetamido-5-(diaminomethylideneamino)pentanoyl]amino]-4-methylpentanoyl]amino]-4,4-dimethylpentanoyl]amino]-4-methylpentanoyl]amino]propanoyl]amino]-5-(diaminomethylideneamino)pentanoic acid Chemical compound NC(=N)NCCC[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(N)=N)NC(C)=O VIJSPAIQWVPKQZ-BLECARSGSA-N 0.000 description 1
• SBTVLCPCSXMWIQ-UHFFFAOYSA-N (3,5-dimethylphenyl) carbamate Chemical compound CC1=CC(C)=CC(OC(N)=O)=C1 SBTVLCPCSXMWIQ-UHFFFAOYSA-N 0.000 description 1
• UDQTXCHQKHIQMH-KYGLGHNPSA-N (3ar,5s,6s,7r,7ar)-5-(difluoromethyl)-2-(ethylamino)-5,6,7,7a-tetrahydro-3ah-pyrano[3,2-d][1,3]thiazole-6,7-diol Chemical compound S1C(NCC)=N[C@H]2[C@@H]1O[C@H](C(F)F)[C@@H](O)[C@@H]2O UDQTXCHQKHIQMH-KYGLGHNPSA-N 0.000 description 1
• HUWSZNZAROKDRZ-RRLWZMAJSA-N (3r,4r)-3-azaniumyl-5-[[(2s,3r)-1-[(2s)-2,3-dicarboxypyrrolidin-1-yl]-3-methyl-1-oxopentan-2-yl]amino]-5-oxo-4-sulfanylpentane-1-sulfonate Chemical compound OS(=O)(=O)CC[C@@H](N)[C@@H](S)C(=O)N[C@@H]([C@H](C)CC)C(=O)N1CCC(C(O)=O)[C@H]1C(O)=O HUWSZNZAROKDRZ-RRLWZMAJSA-N 0.000 description 1
• MPDDTAJMJCESGV-CTUHWIOQSA-M (3r,5r)-7-[2-(4-fluorophenyl)-5-[methyl-[(1r)-1-phenylethyl]carbamoyl]-4-propan-2-ylpyrazol-3-yl]-3,5-dihydroxyheptanoate Chemical compound C1([C@@H](C)N(C)C(=O)C2=NN(C(CC[C@@H](O)C[C@@H](O)CC([O-])=O)=C2C(C)C)C=2C=CC(F)=CC=2)=CC=CC=C1 MPDDTAJMJCESGV-CTUHWIOQSA-M 0.000 description 1
• 125000004178 (C1-C4) alkyl group Chemical group 0.000 description 1
• SYTBZMRGLBWNTM-SNVBAGLBSA-N (R)-flurbiprofen Chemical compound FC1=CC([C@H](C(O)=O)C)=CC=C1C1=CC=CC=C1 SYTBZMRGLBWNTM-SNVBAGLBSA-N 0.000 description 1
• BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
• DYLIWHYUXAJDOJ-OWOJBTEDSA-N (e)-4-(6-aminopurin-9-yl)but-2-en-1-ol Chemical compound NC1=NC=NC2=C1N=CN2C\C=C\CO DYLIWHYUXAJDOJ-OWOJBTEDSA-N 0.000 description 1
• BCMCBBGGLRIHSE-UHFFFAOYSA-N 1,3-benzoxazole Chemical class C1=CC=C2OC=NC2=C1 BCMCBBGGLRIHSE-UHFFFAOYSA-N 0.000 description 1
• YPFDHNVEDLHUCE-UHFFFAOYSA-N 1,3-propanediol Substances OCCCO YPFDHNVEDLHUCE-UHFFFAOYSA-N 0.000 description 1
• UNILWMWFPHPYOR-KXEYIPSPSA-M 1-[6-[2-[3-[3-[3-[2-[2-[3-[[2-[2-[[(2r)-1-[[2-[[(2r)-1-[3-[2-[2-[3-[[2-(2-amino-2-oxoethoxy)acetyl]amino]propoxy]ethoxy]ethoxy]propylamino]-3-hydroxy-1-oxopropan-2-yl]amino]-2-oxoethyl]amino]-3-[(2r)-2,3-di(hexadecanoyloxy)propyl]sulfanyl-1-oxopropan-2-yl Chemical compound O=C1C(SCCC(=O)NCCCOCCOCCOCCCNC(=O)COCC(=O)N[C@@H](CSC[C@@H](COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCCC)C(=O)NCC(=O)N[C@H](CO)C(=O)NCCCOCCOCCOCCCNC(=O)COCC(N)=O)CC(=O)N1CCNC(=O)CCCCCN\1C2=CC=C(S([O-])(=O)=O)C=C2CC/1=C/C=C/C=C/C1=[N+](CC)C2=CC=C(S([O-])(=O)=O)C=C2C1 UNILWMWFPHPYOR-KXEYIPSPSA-M 0.000 description 1
• BHKKSKOHRFHHIN-MRVPVSSYSA-N 1-[[2-[(1R)-1-aminoethyl]-4-chlorophenyl]methyl]-2-sulfanylidene-5H-pyrrolo[3,2-d]pyrimidin-4-one Chemical compound N[C@H](C)C1=C(CN2C(NC(C3=C2C=CN3)=O)=S)C=CC(=C1)Cl BHKKSKOHRFHHIN-MRVPVSSYSA-N 0.000 description 1
• PRIGFEJKMMRJSF-UHFFFAOYSA-M 1-fluoro-2,4,6-trimethylpyridin-1-ium;trifluoromethanesulfonate Chemical compound [O-]S(=O)(=O)C(F)(F)F.CC1=CC(C)=[N+](F)C(C)=C1 PRIGFEJKMMRJSF-UHFFFAOYSA-M 0.000 description 1
• HYZJCKYKOHLVJF-UHFFFAOYSA-N 1H-benzimidazole Chemical class C1=CC=C2NC=NC2=C1 HYZJCKYKOHLVJF-UHFFFAOYSA-N 0.000 description 1
• UPQQXPKAYZYUKO-UHFFFAOYSA-N 2,2,2-trichloroacetamide Chemical compound OC(=N)C(Cl)(Cl)Cl UPQQXPKAYZYUKO-UHFFFAOYSA-N 0.000 description 1
• RTMMSCJWQYWMNK-UHFFFAOYSA-N 2,2,2-trifluoroethyl trifluoromethanesulfonate Chemical compound FC(F)(F)COS(=O)(=O)C(F)(F)F RTMMSCJWQYWMNK-UHFFFAOYSA-N 0.000 description 1
• BOXUZZKOIQVEQP-UHFFFAOYSA-N 2,2,3,3,4,4,4-heptafluorobutanoic acid;rhodium Chemical compound [Rh].[Rh].OC(=O)C(F)(F)C(F)(F)C(F)(F)F.OC(=O)C(F)(F)C(F)(F)C(F)(F)F.OC(=O)C(F)(F)C(F)(F)C(F)(F)F.OC(=O)C(F)(F)C(F)(F)C(F)(F)F BOXUZZKOIQVEQP-UHFFFAOYSA-N 0.000 description 1
• KBXRNBDAFWDLKI-UHFFFAOYSA-N 2-(1h-imidazol-2-yl)pyrazine Chemical class C1=CNC(C=2N=CC=NC=2)=N1 KBXRNBDAFWDLKI-UHFFFAOYSA-N 0.000 description 1
• GCUOLJOTJRUDIZ-UHFFFAOYSA-N 2-(2-bromoethoxy)oxane Chemical compound BrCCOC1CCCCO1 GCUOLJOTJRUDIZ-UHFFFAOYSA-N 0.000 description 1
• VHULROKXGBQUDA-UHFFFAOYSA-N 2-(4-fluoro-2-methylphenyl)acetonitrile Chemical compound CC1=CC(F)=CC=C1CC#N VHULROKXGBQUDA-UHFFFAOYSA-N 0.000 description 1
• AJRHREMZBFKVBP-UHFFFAOYSA-N 2-(5-methoxy-1H-indol-2-yl)-8-[2-(trifluoromethyl)phenyl]-5,6,7,8-tetrahydro-[1,2,4]triazolo[1,5-a]pyridine Chemical compound C=1C2=CC(OC)=CC=C2NC=1C(=NN1CCC2)N=C1C2C1=CC=CC=C1C(F)(F)F AJRHREMZBFKVBP-UHFFFAOYSA-N 0.000 description 1
• XNIOWJUQPMKCIJ-UHFFFAOYSA-N 2-(benzylamino)ethanol Chemical compound OCCNCC1=CC=CC=C1 XNIOWJUQPMKCIJ-UHFFFAOYSA-N 0.000 description 1
• ZDVRPKUWYQVVDX-UHFFFAOYSA-N 2-(trifluoromethyl)benzaldehyde Chemical compound FC(F)(F)C1=CC=CC=C1C=O ZDVRPKUWYQVVDX-UHFFFAOYSA-N 0.000 description 1
• 125000003821 2-(trimethylsilyl)ethoxymethyl group Chemical group [H]C([H])([H])[Si](C([H])([H])[H])(C([H])([H])[H])C([H])([H])C(OC([H])([H])[*])([H])[H] 0.000 description 1
• MOMFXATYAINJML-UHFFFAOYSA-N 2-Acetylthiazole Chemical group CC(=O)C1=NC=CS1 MOMFXATYAINJML-UHFFFAOYSA-N 0.000 description 1
• XNWFRZJHXBZDAG-UHFFFAOYSA-N 2-METHOXYETHANOL Chemical compound COCCO XNWFRZJHXBZDAG-UHFFFAOYSA-N 0.000 description 1
• LBLYYCQCTBFVLH-UHFFFAOYSA-N 2-Methylbenzenesulfonic acid Chemical compound CC1=CC=CC=C1S(O)(=O)=O LBLYYCQCTBFVLH-UHFFFAOYSA-N 0.000 description 1
• QXDCZSJGEUSERL-UHFFFAOYSA-N 2-[2-(trifluoromethyl)phenyl]acetonitrile Chemical compound FC(F)(F)C1=CC=CC=C1CC#N QXDCZSJGEUSERL-UHFFFAOYSA-N 0.000 description 1
• JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 1
• MXGZUNLCDGVHAQ-UHFFFAOYSA-N 2-[5-(4-methylimidazol-1-yl)-1H-pyrrolo[2,3-c]pyridin-2-yl]-8-(2-methylphenyl)-5,6,7,8-tetrahydro-[1,2,4]triazolo[1,5-a]pyridine Chemical compound C1=NC(C)=CN1C(N=C1)=CC2=C1NC(C1=NN3CCCC(C3=N1)C=1C(=CC=CC=1)C)=C2 MXGZUNLCDGVHAQ-UHFFFAOYSA-N 0.000 description 1
• YNDHMPHNXKLPMA-UHFFFAOYSA-N 2-[5-[2-fluoro-5-(trifluoromethyl)phenyl]-5-methyl-6,8-dihydroimidazo[2,1-c][1,4]oxazin-2-yl]-4-methoxy-1h-indole-5-carbonitrile Chemical compound C=1C=2C(OC)=C(C#N)C=CC=2NC=1C(N=1)=CN2C=1COCC2(C)C1=CC(C(F)(F)F)=CC=C1F YNDHMPHNXKLPMA-UHFFFAOYSA-N 0.000 description 1
• PYRKKGOKRMZEIT-UHFFFAOYSA-N 2-[6-(2-cyclopropylethoxy)-9-(2-hydroxy-2-methylpropyl)-1h-phenanthro[9,10-d]imidazol-2-yl]-5-fluorobenzene-1,3-dicarbonitrile Chemical compound C1=C2C3=CC(CC(C)(O)C)=CC=C3C=3NC(C=4C(=CC(F)=CC=4C#N)C#N)=NC=3C2=CC=C1OCCC1CC1 PYRKKGOKRMZEIT-UHFFFAOYSA-N 0.000 description 1
• VUNFRRDDLTXOFL-UHFFFAOYSA-N 2-[8-(2-chlorophenyl)-5,6,7,8-tetrahydro-[1,2,4]triazolo[1,5-a]pyridin-2-yl]-1H-indole-5-carbonitrile Chemical compound ClC1=CC=CC=C1C1C2=NC(C=3NC4=CC=C(C=C4C=3)C#N)=NN2CCC1 VUNFRRDDLTXOFL-UHFFFAOYSA-N 0.000 description 1
• DFKRGXRSWOYYSO-UHFFFAOYSA-N 2-[8-(2-ethyl-4-fluorophenyl)-6,8-dihydro-5H-[1,2,4]triazolo[5,1-c][1,4]oxazin-2-yl]-1H-indole-5-carbonitrile Chemical compound CCC1=CC(F)=CC=C1C1C2=NC(C=3NC4=CC=C(C=C4C=3)C#N)=NN2CCO1 DFKRGXRSWOYYSO-UHFFFAOYSA-N 0.000 description 1
• AZXMTIFBUXOMEE-UHFFFAOYSA-N 2-[8-(2-methoxyphenyl)-5,6,7,8-tetrahydro-[1,2,4]triazolo[1,5-a]pyridin-2-yl]-1H-indole-5-carbonitrile Chemical compound COC1=CC=CC=C1C1C2=NC(C=3NC4=CC=C(C=C4C=3)C#N)=NN2CCC1 AZXMTIFBUXOMEE-UHFFFAOYSA-N 0.000 description 1
• MAOSGKZANFAXHV-UHFFFAOYSA-N 2-[8-(2-methoxyphenyl)-5,6,7,8-tetrahydroimidazo[1,2-a]pyridin-2-yl]-1h-indole-5-carbonitrile Chemical compound COC1=CC=CC=C1C1C2=NC(C=3NC4=CC=C(C=C4C=3)C#N)=CN2CCC1 MAOSGKZANFAXHV-UHFFFAOYSA-N 0.000 description 1
• XXQZGTWABSIQEL-UHFFFAOYSA-N 2-[8-(2-methylphenyl)-5,6,7,8-tetrahydro-[1,2,4]triazolo[1,5-a]pyridin-2-yl]-1H-pyrrolo[2,3-c]pyridine-5-carbonitrile Chemical compound CC1=CC=CC=C1C1C2=NC(C=3NC4=CN=C(C=C4C=3)C#N)=NN2CCC1 XXQZGTWABSIQEL-UHFFFAOYSA-N 0.000 description 1
• VAXYTGZOHRNVLN-UHFFFAOYSA-N 2-[8-(2-methylphenyl)-5,6,7,8-tetrahydro-[1,2,4]triazolo[1,5-a]pyridin-2-yl]-1H-pyrrolo[3,2-b]pyridine-5-carbonitrile Chemical compound CC1=CC=CC=C1C1C2=NC(C=3NC4=CC=C(N=C4C=3)C#N)=NN2CCC1 VAXYTGZOHRNVLN-UHFFFAOYSA-N 0.000 description 1
• JEOPMGIEBUYUBH-UHFFFAOYSA-N 2-[8-(2-methylphenyl)-5,6,7,8-tetrahydroimidazo[1,2-a]pyridin-2-yl]-1h-indole-5-carbonitrile Chemical compound CC1=CC=CC=C1C1C2=NC(C=3NC4=CC=C(C=C4C=3)C#N)=CN2CCC1 JEOPMGIEBUYUBH-UHFFFAOYSA-N 0.000 description 1
• IJEOSSKNGNQFPD-UHFFFAOYSA-N 2-[8-(3-fluoro-2-methylphenyl)-6,8-dihydro-5H-[1,2,4]triazolo[5,1-c][1,4]oxazin-2-yl]-1H-indole-5-carbonitrile Chemical compound CC1=C(F)C=CC=C1C1C2=NC(C=3NC4=CC=C(C=C4C=3)C#N)=NN2CCO1 IJEOSSKNGNQFPD-UHFFFAOYSA-N 0.000 description 1
• HFQZLRLFIYHQPW-UHFFFAOYSA-N 2-[8-(4-fluoro-2-methylphenyl)-5,6,7,8-tetrahydro-[1,2,4]triazolo[1,5-a]pyridin-2-yl]-1H-pyrrolo[2,3-b]pyridine-5-carbonitrile Chemical compound CC1=CC(F)=CC=C1C1C2=NC(C=3NC4=NC=C(C=C4C=3)C#N)=NN2CCC1 HFQZLRLFIYHQPW-UHFFFAOYSA-N 0.000 description 1
• NDROXBVBFCWHGU-UHFFFAOYSA-N 2-[8-(4-fluoro-2-methylphenyl)-5,6,7,8-tetrahydro-[1,2,4]triazolo[1,5-a]pyridin-2-yl]-1H-pyrrolo[2,3-c]pyridine-5-carbonitrile Chemical compound CC1=CC(F)=CC=C1C1C2=NC(C=3NC4=CN=C(C=C4C=3)C#N)=NN2CCC1 NDROXBVBFCWHGU-UHFFFAOYSA-N 0.000 description 1
• FOPPSCNSHAZUGU-UHFFFAOYSA-N 2-[8-(4-fluoro-2-methylphenyl)-5,6,7,8-tetrahydro-[1,2,4]triazolo[1,5-a]pyridin-2-yl]-4-methoxy-1H-indole-5-carbonitrile Chemical compound C=1C=2C(OC)=C(C#N)C=CC=2NC=1C(=NN1CCC2)N=C1C2C1=CC=C(F)C=C1C FOPPSCNSHAZUGU-UHFFFAOYSA-N 0.000 description 1
• QANLUKOQTIGDCX-UHFFFAOYSA-N 2-[8-(4-fluoro-2-methylphenyl)-5,6,7,8-tetrahydroimidazo[1,2-a]pyridin-2-yl]-1h-pyrrolo[2,3-c]pyridine-5-carbonitrile Chemical compound CC1=CC(F)=CC=C1C1C2=NC(C=3NC4=CN=C(C=C4C=3)C#N)=CN2CCC1 QANLUKOQTIGDCX-UHFFFAOYSA-N 0.000 description 1
• UWBHYFPDKTVLBC-UHFFFAOYSA-N 2-[8-(4-fluoro-2-methylphenyl)-5,6,7,8-tetrahydroimidazo[1,2-a]pyridin-2-yl]-4-methoxy-1h-indole-5-carbonitrile Chemical compound C=1C=2C(OC)=C(C#N)C=CC=2NC=1C(N=C12)=CN1CCCC2C1=CC=C(F)C=C1C UWBHYFPDKTVLBC-UHFFFAOYSA-N 0.000 description 1
• UMAUKBQUICMSGM-UHFFFAOYSA-N 2-[8-(4-fluoro-2-methylphenyl)-6,8-dihydro-5H-[1,2,4]triazolo[5,1-c][1,4]oxazin-2-yl]-4-propan-2-yloxy-1H-indole-5-carbonitrile Chemical compound C=1C=2C(OC(C)C)=C(C#N)C=CC=2NC=1C(=NN1CCO2)N=C1C2C1=CC=C(F)C=C1C UMAUKBQUICMSGM-UHFFFAOYSA-N 0.000 description 1
• XTFXJUPJAPRNDY-UHFFFAOYSA-N 2-[8-(4-fluoro-2-methylphenyl)-6,8-dihydro-5h-imidazo[2,1-c][1,4]oxazin-2-yl]-4-(2-methoxyethoxy)-1h-indole-5-carbonitrile Chemical compound C=1C=2C(OCCOC)=C(C#N)C=CC=2NC=1C(N=C12)=CN1CCOC2C1=CC=C(F)C=C1C XTFXJUPJAPRNDY-UHFFFAOYSA-N 0.000 description 1
• PNUYEGOLKNLEEW-UHFFFAOYSA-N 2-[8-(4-fluoro-2-methylphenyl)-7-methyl-6,8-dihydro-5H-[1,2,4]triazolo[1,5-a]pyrazin-2-yl]-4-methoxy-1H-indole-5-carbonitrile Chemical compound C=1C=2C(OC)=C(C#N)C=CC=2NC=1C(=NN1CCN2C)N=C1C2C1=CC=C(F)C=C1C PNUYEGOLKNLEEW-UHFFFAOYSA-N 0.000 description 1
• XQYDHPXBLGKWEV-UHFFFAOYSA-N 2-[8-(4-fluoro-2-methylphenyl)-8-hydroxy-6,7-dihydro-5H-[1,2,4]triazolo[1,5-a]pyridin-2-yl]-4-methoxy-1H-indole-5-carbonitrile Chemical compound C=1C=2C(OC)=C(C#N)C=CC=2NC=1C(=N1)N=C2N1CCCC2(O)C1=CC=C(F)C=C1C XQYDHPXBLGKWEV-UHFFFAOYSA-N 0.000 description 1
• NSNZQUJPRAJCCE-UHFFFAOYSA-N 2-[8-[2-(trifluoromethoxy)phenyl]-5,6,7,8-tetrahydro-[1,2,4]triazolo[1,5-a]pyridin-2-yl]-1H-indole-5-carbonitrile Chemical compound FC(F)(F)OC1=CC=CC=C1C1C2=NC(C=3NC4=CC=C(C=C4C=3)C#N)=NN2CCC1 NSNZQUJPRAJCCE-UHFFFAOYSA-N 0.000 description 1
• BIAGFKPGZKDONZ-UHFFFAOYSA-N 2-[8-[2-(trifluoromethyl)phenyl]-5,6,7,8-tetrahydro-[1,2,4]triazolo[1,5-a]pyridin-2-yl]-1H-indole-5-carbonitrile Chemical compound FC(F)(F)C1=CC=CC=C1C1C2=NC(C=3NC4=CC=C(C=C4C=3)C#N)=NN2CCC1 BIAGFKPGZKDONZ-UHFFFAOYSA-N 0.000 description 1
• IRHFDODITIAWMC-UHFFFAOYSA-N 2-[8-[2-(trifluoromethyl)phenyl]-5,6,7,8-tetrahydro-[1,2,4]triazolo[1,5-a]pyridin-2-yl]-1H-indole-6-carbonitrile Chemical compound FC(F)(F)C1=CC=CC=C1C1C2=NC(C=3NC4=CC(=CC=C4C=3)C#N)=NN2CCC1 IRHFDODITIAWMC-UHFFFAOYSA-N 0.000 description 1
• KDOBRKUMVARMLF-UHFFFAOYSA-N 2-[8-[2-(trifluoromethyl)phenyl]-5,6,7,8-tetrahydro-[1,2,4]triazolo[1,5-a]pyridin-2-yl]-1H-pyrrolo[3,2-b]pyridine-5-carbonitrile Chemical compound FC(F)(F)C1=CC=CC=C1C1C2=NC(C=3NC4=CC=C(N=C4C=3)C#N)=NN2CCC1 KDOBRKUMVARMLF-UHFFFAOYSA-N 0.000 description 1
• BSFWYQZUAVCSSD-UHFFFAOYSA-N 2-[8-[2-(trifluoromethyl)phenyl]-5,6,7,8-tetrahydro-[1,2,4]triazolo[1,5-a]pyridin-2-yl]-3H-benzimidazole-5-carbonitrile Chemical compound FC(F)(F)C1=CC=CC=C1C1C2=NC(C=3NC4=CC=C(C=C4N=3)C#N)=NN2CCC1 BSFWYQZUAVCSSD-UHFFFAOYSA-N 0.000 description 1
• SDMRGBJINBSWGF-UHFFFAOYSA-N 2-[8-[2-(trifluoromethyl)phenyl]-5,6,7,8-tetrahydroimidazo[1,2-a]pyridin-2-yl]-1h-indole-5-carbonitrile Chemical compound FC(F)(F)C1=CC=CC=C1C1C2=NC(C=3NC4=CC=C(C=C4C=3)C#N)=CN2CCC1 SDMRGBJINBSWGF-UHFFFAOYSA-N 0.000 description 1
• VRFIBYMMJHGHCY-UHFFFAOYSA-N 2-[8-[2-(trifluoromethyl)phenyl]-6,8-dihydro-5H-[1,2,4]triazolo[5,1-c][1,4]oxazin-2-yl]-1H-indole-5-carbonitrile Chemical compound FC(F)(F)C1=CC=CC=C1C1C2=NC(C=3NC4=CC=C(C=C4C=3)C#N)=NN2CCO1 VRFIBYMMJHGHCY-UHFFFAOYSA-N 0.000 description 1
• SDSNTORALCVVNR-UHFFFAOYSA-N 2-[8-[2-fluoro-5-(trifluoromethyl)phenyl]-5,6,7,8-tetrahydro-[1,2,4]triazolo[1,5-a]pyridin-2-yl]-1H-indole-5-carbonitrile Chemical compound FC1=CC=C(C(F)(F)F)C=C1C1C2=NC(C=3NC4=CC=C(C=C4C=3)C#N)=NN2CCC1 SDSNTORALCVVNR-UHFFFAOYSA-N 0.000 description 1
• IRBIRDMFVPWANJ-UHFFFAOYSA-N 2-[8-[2-methyl-5-(trifluoromethyl)phenyl]-5,6,7,8-tetrahydro-[1,2,4]triazolo[1,5-a]pyridin-2-yl]-1H-pyrrolo[2,3-b]pyridine-5-carbonitrile Chemical compound CC1=CC=C(C(F)(F)F)C=C1C1C2=NC(C=3NC4=NC=C(C=C4C=3)C#N)=NN2CCC1 IRBIRDMFVPWANJ-UHFFFAOYSA-N 0.000 description 1
• WLCZEMGXDQYUIO-UHFFFAOYSA-N 2-[8-[2-methyl-5-(trifluoromethyl)phenyl]-6,8-dihydro-5H-[1,2,4]triazolo[5,1-c][1,4]oxazin-2-yl]-1H-indole-5-carbonitrile Chemical compound CC1=CC=C(C(F)(F)F)C=C1C1C2=NC(C=3NC4=CC=C(C=C4C=3)C#N)=NN2CCO1 WLCZEMGXDQYUIO-UHFFFAOYSA-N 0.000 description 1
• MMBLPWVBKIMIPB-UHFFFAOYSA-N 2-[8-[3-(trifluoromethoxy)phenyl]-5,6,7,8-tetrahydro-[1,2,4]triazolo[1,5-a]pyridin-2-yl]-1H-indole-5-carbonitrile Chemical compound FC(F)(F)OC1=CC=CC(C2C3=NC(=NN3CCC2)C=2NC3=CC=C(C=C3C=2)C#N)=C1 MMBLPWVBKIMIPB-UHFFFAOYSA-N 0.000 description 1
• SBJYGLWYBXZUAW-UHFFFAOYSA-N 2-[8-[3-fluoro-2-(trifluoromethyl)phenyl]-6,8-dihydro-5H-[1,2,4]triazolo[5,1-c][1,4]oxazin-2-yl]-4-methoxy-1H-indole-5-carbonitrile Chemical compound C=1C=2C(OC)=C(C#N)C=CC=2NC=1C(=NN1CCO2)N=C1C2C1=CC=CC(F)=C1C(F)(F)F SBJYGLWYBXZUAW-UHFFFAOYSA-N 0.000 description 1
• XAHACJVPFAHZLL-UHFFFAOYSA-N 2-[8-[4-fluoro-2-(trifluoromethyl)phenyl]-5,6,7,8-tetrahydro-[1,2,4]triazolo[1,5-a]pyridin-2-yl]-1H-indole-5-carbonitrile Chemical compound FC(F)(F)C1=CC(F)=CC=C1C1C2=NC(C=3NC4=CC=C(C=C4C=3)C#N)=NN2CCC1 XAHACJVPFAHZLL-UHFFFAOYSA-N 0.000 description 1
• FMKGJQHNYMWDFJ-CVEARBPZSA-N 2-[[4-(2,2-difluoropropoxy)pyrimidin-5-yl]methylamino]-4-[[(1R,4S)-4-hydroxy-3,3-dimethylcyclohexyl]amino]pyrimidine-5-carbonitrile Chemical compound FC(COC1=NC=NC=C1CNC1=NC=C(C(=N1)N[C@H]1CC([C@H](CC1)O)(C)C)C#N)(C)F FMKGJQHNYMWDFJ-CVEARBPZSA-N 0.000 description 1
• TWWUWLMGYSLODU-UHFFFAOYSA-N 2-bromo-1-methyl-4-(trifluoromethyl)benzene Chemical compound CC1=CC=C(C(F)(F)F)C=C1Br TWWUWLMGYSLODU-UHFFFAOYSA-N 0.000 description 1
• FPYUJUBAXZAQNL-UHFFFAOYSA-N 2-chlorobenzaldehyde Chemical compound ClC1=CC=CC=C1C=O FPYUJUBAXZAQNL-UHFFFAOYSA-N 0.000 description 1
• PTPDIZSYEDIWFK-UHFFFAOYSA-N 2-iodo-1h-indole-5-carbonitrile Chemical compound N#CC1=CC=C2NC(I)=CC2=C1 PTPDIZSYEDIWFK-UHFFFAOYSA-N 0.000 description 1
• BMIBJCFFZPYJHF-UHFFFAOYSA-N 2-methoxy-5-methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine Chemical compound COC1=NC=C(C)C=C1B1OC(C)(C)C(C)(C)O1 BMIBJCFFZPYJHF-UHFFFAOYSA-N 0.000 description 1
• LFOIDLOIBZFWDO-UHFFFAOYSA-N 2-methoxy-6-[6-methoxy-4-[(3-phenylmethoxyphenyl)methoxy]-1-benzofuran-2-yl]imidazo[2,1-b][1,3,4]thiadiazole Chemical compound N1=C2SC(OC)=NN2C=C1C(OC1=CC(OC)=C2)=CC1=C2OCC(C=1)=CC=CC=1OCC1=CC=CC=C1 LFOIDLOIBZFWDO-UHFFFAOYSA-N 0.000 description 1
• FRAKFBWDPXYIQO-UHFFFAOYSA-N 3,5-dibromo-1h-1,2,4-triazole Chemical compound BrC1=NNC(Br)=N1 FRAKFBWDPXYIQO-UHFFFAOYSA-N 0.000 description 1
• STBGLXMINLWCNL-UHFFFAOYSA-N 3-bromo-2-hydroxybenzaldehyde Chemical compound OC1=C(Br)C=CC=C1C=O STBGLXMINLWCNL-UHFFFAOYSA-N 0.000 description 1
• RBCARPJOEUEZLS-UHFFFAOYSA-N 3-bromopyridin-2-amine Chemical compound NC1=NC=CC=C1Br RBCARPJOEUEZLS-UHFFFAOYSA-N 0.000 description 1
• FBKAGWTYLUGJDP-UHFFFAOYSA-N 4-(2,2-difluoroethoxy)-2-[8-(4-fluoro-2-methylphenyl)-6,8-dihydro-5H-[1,2,4]triazolo[5,1-c][1,4]oxazin-2-yl]-1H-indole-5-carbonitrile Chemical compound CC1=CC(F)=CC=C1C1C2=NC(C=3NC4=CC=C(C(OCC(F)F)=C4C=3)C#N)=NN2CCO1 FBKAGWTYLUGJDP-UHFFFAOYSA-N 0.000 description 1
• WUBBRNOQWQTFEX-UHFFFAOYSA-N 4-aminosalicylic acid Chemical compound NC1=CC=C(C(O)=O)C(O)=C1 WUBBRNOQWQTFEX-UHFFFAOYSA-N 0.000 description 1
• FOKVNBQSMNGHLL-UHFFFAOYSA-N 4-ethoxy-2-[8-(4-fluoro-2-methylphenyl)-6,8-dihydro-5H-[1,2,4]triazolo[5,1-c][1,4]oxazin-2-yl]-1H-indole-5-carbonitrile Chemical compound C=1C=2C(OCC)=C(C#N)C=CC=2NC=1C(=NN1CCO2)N=C1C2C1=CC=C(F)C=C1C FOKVNBQSMNGHLL-UHFFFAOYSA-N 0.000 description 1
• IHCUUUPUTSNNMH-UHFFFAOYSA-N 4-methoxy-2-(5-phenyl-6,8-dihydro-5h-imidazo[2,1-c][1,4]oxazin-2-yl)-1h-indole-5-carbonitrile Chemical compound C=1C=2C(OC)=C(C#N)C=CC=2NC=1C(N=C1COC2)=CN1C2C1=CC=CC=C1 IHCUUUPUTSNNMH-UHFFFAOYSA-N 0.000 description 1
• MVLQSAIIKQCXDH-UHFFFAOYSA-N 4-methoxy-2-[8-[2-(trifluoromethyl)phenyl]-5,6,7,8-tetrahydro-[1,2,4]triazolo[1,5-a]pyridin-2-yl]-1H-indole-5-carbonitrile Chemical compound C=1C=2C(OC)=C(C#N)C=CC=2NC=1C(=NN1CCC2)N=C1C2C1=CC=CC=C1C(F)(F)F MVLQSAIIKQCXDH-UHFFFAOYSA-N 0.000 description 1
• KBIWNQVZKHSHTI-UHFFFAOYSA-N 4-n,4-n-dimethylbenzene-1,4-diamine;oxalic acid Chemical compound OC(=O)C(O)=O.CN(C)C1=CC=C(N)C=C1 KBIWNQVZKHSHTI-UHFFFAOYSA-N 0.000 description 1
• WVRNTDOWZRUIKE-UHFFFAOYSA-N 5-bromo-1h-pyrrolo[2,3-b]pyridine-2-carboxylic acid Chemical compound BrC1=CN=C2NC(C(=O)O)=CC2=C1 WVRNTDOWZRUIKE-UHFFFAOYSA-N 0.000 description 1
• CVJJRJYVLCPZJP-UHFFFAOYSA-N 5-methyl-1-(2,2,2-trifluoroethyl)pyrazole Chemical compound CC1=CC=NN1CC(F)(F)F CVJJRJYVLCPZJP-UHFFFAOYSA-N 0.000 description 1
• GXDVCRCMLDJGAS-UHFFFAOYSA-N 5-phenylmorpholin-3-one Chemical compound N1C(=O)COCC1C1=CC=CC=C1 GXDVCRCMLDJGAS-UHFFFAOYSA-N 0.000 description 1
• CKUQTHSGTPGGFK-UHFFFAOYSA-N 6-amino-5-bromopyridine-3-carbonitrile Chemical compound NC1=NC=C(C#N)C=C1Br CKUQTHSGTPGGFK-UHFFFAOYSA-N 0.000 description 1
• ULTDLMITPWHISY-UHFFFAOYSA-N 6-bromo-1h-benzimidazole-2-carboxylic acid Chemical compound C1=C(Br)C=C2NC(C(=O)O)=NC2=C1 ULTDLMITPWHISY-UHFFFAOYSA-N 0.000 description 1
• LXYWOOBKIKICMZ-UHFFFAOYSA-N 6-methoxy-2-[8-[2-(trifluoromethyl)phenyl]-5,6,7,8-tetrahydro-[1,2,4]triazolo[1,5-a]pyridin-2-yl]-1H-indole-5-carbonitrile Chemical compound C=1C=2C=C(C#N)C(OC)=CC=2NC=1C(=NN1CCC2)N=C1C2C1=CC=CC=C1C(F)(F)F LXYWOOBKIKICMZ-UHFFFAOYSA-N 0.000 description 1
• HCCNBKFJYUWLEX-UHFFFAOYSA-N 7-(6-methoxypyridin-3-yl)-1-(2-propoxyethyl)-3-(pyrazin-2-ylmethylamino)pyrido[3,4-b]pyrazin-2-one Chemical compound O=C1N(CCOCCC)C2=CC(C=3C=NC(OC)=CC=3)=NC=C2N=C1NCC1=CN=CC=N1 HCCNBKFJYUWLEX-UHFFFAOYSA-N 0.000 description 1
• ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
• GJTXLGLXTMKBIQ-UHFFFAOYSA-N 8-(2-ethyl-4-fluorophenyl)-2-[5-(4-methylimidazol-1-yl)-1H-indol-2-yl]-6,8-dihydro-5H-[1,2,4]triazolo[5,1-c][1,4]oxazine Chemical compound CCC1=CC(F)=CC=C1C1C2=NC(C=3NC4=CC=C(C=C4C=3)N3C=C(C)N=C3)=NN2CCO1 GJTXLGLXTMKBIQ-UHFFFAOYSA-N 0.000 description 1
• YWPANHFMVMHEFO-UHFFFAOYSA-N 8-(2-methylphenyl)-2-[5-(1-methylpyrazol-4-yl)-1H-indol-2-yl]-5,6,7,8-tetrahydro-[1,2,4]triazolo[1,5-a]pyridine Chemical compound CC1=CC=CC=C1C1C2=NC(C=3NC4=CC=C(C=C4C=3)C3=CN(C)N=C3)=NN2CCC1 YWPANHFMVMHEFO-UHFFFAOYSA-N 0.000 description 1
• FHVCMZGZCMTLTM-UHFFFAOYSA-N 8-(2-methylphenyl)-2-[5-(2-methylpyridin-4-yl)-1H-pyrrolo[3,2-b]pyridin-2-yl]-5,6,7,8-tetrahydro-[1,2,4]triazolo[1,5-a]pyridine Chemical compound C1=NC(C)=CC(C=2N=C3C=C(NC3=CC=2)C2=NN3CCCC(C3=N2)C=2C(=CC=CC=2)C)=C1 FHVCMZGZCMTLTM-UHFFFAOYSA-N 0.000 description 1
• IMAPKDPPQLCVKS-UHFFFAOYSA-N 8-(3,4-difluoro-2-methylphenyl)-2-[5-(4-methylimidazol-1-yl)-1H-indol-2-yl]-6,8-dihydro-5H-[1,2,4]triazolo[5,1-c][1,4]oxazine Chemical compound C1=NC(C)=CN1C1=CC=C(NC(=C2)C3=NN4CCOC(C4=N3)C=3C(=C(F)C(F)=CC=3)C)C2=C1 IMAPKDPPQLCVKS-UHFFFAOYSA-N 0.000 description 1
• YUXAABSTWQZBFD-UHFFFAOYSA-N 8-(3-fluoro-2-methylphenyl)-2-[5-(4-methylimidazol-1-yl)-1H-indol-2-yl]-6,8-dihydro-5H-[1,2,4]triazolo[5,1-c][1,4]oxazine Chemical compound C1=NC(C)=CN1C1=CC=C(NC(=C2)C3=NN4CCOC(C4=N3)C=3C(=C(F)C=CC=3)C)C2=C1 YUXAABSTWQZBFD-UHFFFAOYSA-N 0.000 description 1
• KYRSOKTYPVZXGZ-UHFFFAOYSA-N 8-(4,5-difluoro-2,3-dimethylphenyl)-2-[5-(4-methylimidazol-1-yl)-1H-indol-2-yl]-6,8-dihydro-5H-[1,2,4]triazolo[5,1-c][1,4]oxazine Chemical compound C1=NC(C)=CN1C1=CC=C(NC(=C2)C3=NN4CCOC(C4=N3)C=3C(=C(C)C(F)=C(F)C=3)C)C2=C1 KYRSOKTYPVZXGZ-UHFFFAOYSA-N 0.000 description 1
• NCEFWJIMGXRDRW-UHFFFAOYSA-N 8-(4-fluoro-2-methylphenyl)-2-[4-methoxy-5-(1-methylpyrazol-4-yl)-1h-indol-2-yl]-6,8-dihydro-5h-imidazo[2,1-c][1,4]oxazine Chemical compound C=1C=2C(OC)=C(C3=CN(C)N=C3)C=CC=2NC=1C(N=C12)=CN1CCOC2C1=CC=C(F)C=C1C NCEFWJIMGXRDRW-UHFFFAOYSA-N 0.000 description 1
• ODBDFSCEERMKDZ-UHFFFAOYSA-N 8-(4-fluoro-2-methylphenyl)-2-[5-(1-methylpyrazol-4-yl)-1H-indol-2-yl]-6,8-dihydro-5H-[1,2,4]triazolo[5,1-c][1,4]oxazine Chemical compound CC1=CC(F)=CC=C1C1C2=NC(C=3NC4=CC=C(C=C4C=3)C3=CN(C)N=C3)=NN2CCO1 ODBDFSCEERMKDZ-UHFFFAOYSA-N 0.000 description 1
• PBARAUJEVKQDKA-UHFFFAOYSA-N 8-(4-fluoro-2-methylphenyl)-2-[5-(1-methylpyrazol-4-yl)-1H-pyrrolo[3,2-b]pyridin-2-yl]-6,8-dihydro-5H-[1,2,4]triazolo[5,1-c][1,4]oxazine Chemical compound CC1=CC(F)=CC=C1C1C2=NC(C=3NC4=CC=C(N=C4C=3)C3=CN(C)N=C3)=NN2CCO1 PBARAUJEVKQDKA-UHFFFAOYSA-N 0.000 description 1
• MAFSNAGKCDRWSB-UHFFFAOYSA-N 8-(4-fluoro-2-methylphenyl)-2-[5-(1-methylpyrazol-4-yl)-1h-indol-2-yl]-6,8-dihydro-5h-imidazo[2,1-c][1,4]oxazine Chemical compound CC1=CC(F)=CC=C1C1C2=NC(C=3NC4=CC=C(C=C4C=3)C3=CN(C)N=C3)=CN2CCO1 MAFSNAGKCDRWSB-UHFFFAOYSA-N 0.000 description 1
• XQZDCTKOMDWSTA-UHFFFAOYSA-N 8-(4-fluoro-2-methylphenyl)-2-[5-(2-methylpyridin-4-yl)-1H-indol-2-yl]-6,8-dihydro-5H-[1,2,4]triazolo[5,1-c][1,4]oxazine Chemical compound C1=NC(C)=CC(C=2C=C3C=C(NC3=CC=2)C2=NN3CCOC(C3=N2)C=2C(=CC(F)=CC=2)C)=C1 XQZDCTKOMDWSTA-UHFFFAOYSA-N 0.000 description 1
• JYCPHBOOMOCSLV-UHFFFAOYSA-N 8-(4-fluoro-2-methylphenyl)-2-[5-(2-methylpyridin-4-yl)-1H-pyrrolo[3,2-b]pyridin-2-yl]-5,6,7,8-tetrahydro-[1,2,4]triazolo[1,5-a]pyridine Chemical compound C1=NC(C)=CC(C=2N=C3C=C(NC3=CC=2)C2=NN3CCCC(C3=N2)C=2C(=CC(F)=CC=2)C)=C1 JYCPHBOOMOCSLV-UHFFFAOYSA-N 0.000 description 1
• PBSABHFRVGNRDP-UHFFFAOYSA-N 8-(4-fluoro-2-methylphenyl)-2-[5-(3-methyl-1,2,4-triazol-1-yl)-1H-indol-2-yl]-5,6,7,8-tetrahydro-[1,2,4]triazolo[1,5-a]pyridine Chemical compound N1=C(C)N=CN1C1=CC=C(NC(=C2)C3=NN4CCCC(C4=N3)C=3C(=CC(F)=CC=3)C)C2=C1 PBSABHFRVGNRDP-UHFFFAOYSA-N 0.000 description 1
• QAIFTQMWOFAPKL-UHFFFAOYSA-N 8-(4-fluoro-2-methylphenyl)-2-[5-(4-methylimidazol-1-yl)-1H-pyrrolo[2,3-c]pyridin-2-yl]-5,6,7,8-tetrahydro-[1,2,4]triazolo[1,5-a]pyridine Chemical compound C1=NC(C)=CN1C(N=C1)=CC2=C1NC(C1=NN3CCCC(C3=N1)C=1C(=CC(F)=CC=1)C)=C2 QAIFTQMWOFAPKL-UHFFFAOYSA-N 0.000 description 1
• RJLRLFGYTHYZOF-UHFFFAOYSA-N 8-(4-fluoro-2-methylphenyl)-2-[5-(4-methylimidazol-1-yl)-1H-pyrrolo[3,2-b]pyridin-2-yl]-6,8-dihydro-5H-[1,2,4]triazolo[5,1-c][1,4]oxazine Chemical compound C1=NC(C)=CN1C1=CC=C(NC(=C2)C3=NN4CCOC(C4=N3)C=3C(=CC(F)=CC=3)C)C2=N1 RJLRLFGYTHYZOF-UHFFFAOYSA-N 0.000 description 1
• GDYOZDTWWGPVFA-UHFFFAOYSA-N 8-(4-fluoro-2-methylphenyl)-2-[5-(5-methyl-1,2,4-triazol-1-yl)-1H-indol-2-yl]-5,6,7,8-tetrahydro-[1,2,4]triazolo[1,5-a]pyridine Chemical compound CC1=NC=NN1C1=CC=C(NC(=C2)C3=NN4CCCC(C4=N3)C=3C(=CC(F)=CC=3)C)C2=C1 GDYOZDTWWGPVFA-UHFFFAOYSA-N 0.000 description 1
• GTIFECDBXYVTQY-UHFFFAOYSA-N 8-(4-fluoro-2-methylphenyl)-2-[6-(4-methylimidazol-1-yl)-1H-indol-2-yl]-5,6,7,8-tetrahydro-[1,2,4]triazolo[1,5-a]pyridine Chemical compound C1=NC(C)=CN1C1=CC=C(C=C(N2)C3=NN4CCCC(C4=N3)C=3C(=CC(F)=CC=3)C)C2=C1 GTIFECDBXYVTQY-UHFFFAOYSA-N 0.000 description 1
• WVVJNLJORBXYPW-UHFFFAOYSA-N 8-(4-fluoro-2-methylphenyl)-2-[6-(5-methylimidazol-1-yl)-1H-benzimidazol-2-yl]-5,6,7,8-tetrahydro-[1,2,4]triazolo[1,5-a]pyridine Chemical compound CC1=CN=CN1C1=CC=C(NC(=N2)C3=NN4CCCC(C4=N3)C=3C(=CC(F)=CC=3)C)C2=C1 WVVJNLJORBXYPW-UHFFFAOYSA-N 0.000 description 1
• NCFAFWDYRCJUCS-UHFFFAOYSA-N 8-(4-fluoro-2-propan-2-ylphenyl)-2-[5-(4-methylimidazol-1-yl)-1H-indol-2-yl]-6,8-dihydro-5H-[1,2,4]triazolo[5,1-c][1,4]oxazine Chemical compound CC(C)C1=CC(F)=CC=C1C1C2=NC(C=3NC4=CC=C(C=C4C=3)N3C=C(C)N=C3)=NN2CCO1 NCFAFWDYRCJUCS-UHFFFAOYSA-N 0.000 description 1
• 108700028369 Alleles Proteins 0.000 description 1
• 102100033312 Alpha-2-macroglobulin Human genes 0.000 description 1
• 229920001450 Alpha-Cyclodextrin Polymers 0.000 description 1
• 239000005995 Aluminium silicate Substances 0.000 description 1
• KLSJWNVTNUYHDU-UHFFFAOYSA-N Amitrole Chemical class NC1=NC=NN1 KLSJWNVTNUYHDU-UHFFFAOYSA-N 0.000 description 1
• QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
• ATRRKUHOCOJYRX-UHFFFAOYSA-N Ammonium bicarbonate Chemical compound [NH4+].OC([O-])=O ATRRKUHOCOJYRX-UHFFFAOYSA-N 0.000 description 1
• 229910000013 Ammonium bicarbonate Inorganic materials 0.000 description 1
• 208000000044 Amnesia Diseases 0.000 description 1
• 101710137189 Amyloid-beta A4 protein Proteins 0.000 description 1
• 101710151993 Amyloid-beta precursor protein Proteins 0.000 description 1
• 101800001718 Amyloid-beta protein Proteins 0.000 description 1
• 102000009091 Amyloidogenic Proteins Human genes 0.000 description 1
• 108010048112 Amyloidogenic Proteins Proteins 0.000 description 1
• 229920000856 Amylose Polymers 0.000 description 1
• 239000004475 Arginine Substances 0.000 description 1
• LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 1
• 238000006418 Brown reaction Methods 0.000 description 1
• OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
• 208000024172 Cardiovascular disease Diseases 0.000 description 1
• 240000004307 Citrus medica Species 0.000 description 1
• 238000003512 Claisen condensation reaction Methods 0.000 description 1
• 108091026890 Coding region Proteins 0.000 description 1
• FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
• FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
• 235000019739 Dicalciumphosphate Nutrition 0.000 description 1
• MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 1
• 102000004190 Enzymes Human genes 0.000 description 1
• 108090000790 Enzymes Proteins 0.000 description 1
• 230000005526 G1 to G0 transition Effects 0.000 description 1
• 208000010412 Glaucoma Diseases 0.000 description 1
• 206010019196 Head injury Diseases 0.000 description 1
• AVXURJPOCDRRFD-UHFFFAOYSA-N Hydroxylamine Chemical compound ON AVXURJPOCDRRFD-UHFFFAOYSA-N 0.000 description 1
• MFESCIUQSIBMSM-UHFFFAOYSA-N I-BCP Chemical compound ClCCCBr MFESCIUQSIBMSM-UHFFFAOYSA-N 0.000 description 1
• GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
• 239000004166 Lanolin Substances 0.000 description 1
• WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
• KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
• 239000004472 Lysine Substances 0.000 description 1
• FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
• 239000012359 Methanesulfonyl chloride Substances 0.000 description 1
• MBBZMMPHUWSWHV-BDVNFPICSA-N N-methylglucamine Chemical class CNC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO MBBZMMPHUWSWHV-BDVNFPICSA-N 0.000 description 1
• 206010029260 Neuroblastoma Diseases 0.000 description 1
• GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
• 235000019502 Orange oil Nutrition 0.000 description 1
• 229930040373 Paraformaldehyde Natural products 0.000 description 1
• 235000019483 Peanut oil Nutrition 0.000 description 1
• 101000579647 Penaeus vannamei Penaeidin-2a Proteins 0.000 description 1
• ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
• 108010015078 Pregnancy-Associated alpha 2-Macroglobulins Proteins 0.000 description 1
• 108010029485 Protein Isoforms Proteins 0.000 description 1
• 102000001708 Protein Isoforms Human genes 0.000 description 1
• 101710150593 Protein beta Proteins 0.000 description 1
• KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 1
• PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
• DWAQJAXMDSEUJJ-UHFFFAOYSA-M Sodium bisulfite Chemical compound [Na+].OS([O-])=O DWAQJAXMDSEUJJ-UHFFFAOYSA-M 0.000 description 1
• 229920002472 Starch Polymers 0.000 description 1
• 108010090804 Streptavidin Proteins 0.000 description 1
• NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
• FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
• PSLUFJFHTBIXMW-WYEYVKMPSA-N [(3r,4ar,5s,6s,6as,10s,10ar,10bs)-3-ethenyl-10,10b-dihydroxy-3,4a,7,7,10a-pentamethyl-1-oxo-6-(2-pyridin-2-ylethylcarbamoyloxy)-5,6,6a,8,9,10-hexahydro-2h-benzo[f]chromen-5-yl] acetate Chemical compound O([C@@H]1[C@@H]([C@]2(O[C@](C)(CC(=O)[C@]2(O)[C@@]2(C)[C@@H](O)CCC(C)(C)[C@@H]21)C=C)C)OC(=O)C)C(=O)NCCC1=CC=CC=N1 PSLUFJFHTBIXMW-WYEYVKMPSA-N 0.000 description 1
• DACWQSNZECJJGG-UHFFFAOYSA-N [1,2,4]triazolo[1,5-a]pyridine Chemical class C1=CC=CN2N=CN=C21 DACWQSNZECJJGG-UHFFFAOYSA-N 0.000 description 1
• BFPLMTPHDFFMTG-UHFFFAOYSA-N [1,3]oxazolo[5,4-b]pyridine Chemical class C1=CN=C2OC=NC2=C1 BFPLMTPHDFFMTG-UHFFFAOYSA-N 0.000 description 1
• ZUSWDTWYONAOPH-UHFFFAOYSA-N [2-(trifluoromethyl)phenyl]hydrazine;hydrochloride Chemical group [Cl-].[NH3+]NC1=CC=CC=C1C(F)(F)F ZUSWDTWYONAOPH-UHFFFAOYSA-N 0.000 description 1
• FGYQCPHMXZEQPZ-UHFFFAOYSA-N [2-[8-(4-fluoro-2-methylphenyl)-5,6,7,8-tetrahydro-[1,2,4]triazolo[1,5-a]pyridin-2-yl]-5-(4-methylimidazol-1-yl)-1H-pyrrolo[3,2-b]pyridin-3-yl]methanol Chemical compound C1=NC(C)=CN1C1=CC=C(NC(C2=NN3CCCC(C3=N2)C=2C(=CC(F)=CC=2)C)=C2CO)C2=N1 FGYQCPHMXZEQPZ-UHFFFAOYSA-N 0.000 description 1
• AJWYBPNMPKTRDV-UHFFFAOYSA-N [5-cyano-1-[(2-methylpropan-2-yl)oxycarbonyl]indol-2-yl]boronic acid Chemical compound N#CC1=CC=C2N(C(=O)OC(C)(C)C)C(B(O)O)=CC2=C1 AJWYBPNMPKTRDV-UHFFFAOYSA-N 0.000 description 1
• DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
• WETWJCDKMRHUPV-UHFFFAOYSA-N acetyl chloride Chemical compound CC(Cl)=O WETWJCDKMRHUPV-UHFFFAOYSA-N 0.000 description 1
• 230000009471 action Effects 0.000 description 1
• 230000004913 activation Effects 0.000 description 1
• 150000001263 acyl chlorides Chemical class 0.000 description 1
• 230000002411 adverse Effects 0.000 description 1
• 239000003513 alkali Substances 0.000 description 1
• BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
• 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
• 235000012211 aluminium silicate Nutrition 0.000 description 1
• 230000007792 alzheimer disease pathology Effects 0.000 description 1
• 150000001412 amines Chemical class 0.000 description 1
• 150000001413 amino acids Chemical group 0.000 description 1
• 125000003277 amino group Chemical group 0.000 description 1
• 229960004909 aminosalicylic acid Drugs 0.000 description 1
• 235000012538 ammonium bicarbonate Nutrition 0.000 description 1
• 239000001099 ammonium carbonate Substances 0.000 description 1
• 235000019270 ammonium chloride Nutrition 0.000 description 1
• DZHSAHHDTRWUTF-SIQRNXPUSA-N amyloid-beta polypeptide 42 Chemical compound C([C@@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(O)=O)[C@@H](C)CC)C(C)C)NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC=1N=CNC=1)NC(=O)[C@H](CC=1N=CNC=1)NC(=O)[C@@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1N=CNC=1)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC(O)=O)C(C)C)C(C)C)C1=CC=CC=C1 DZHSAHHDTRWUTF-SIQRNXPUSA-N 0.000 description 1
• 230000003941 amyloidogenesis Effects 0.000 description 1
• 230000003942 amyloidogenic effect Effects 0.000 description 1
• 239000000427 antigen Substances 0.000 description 1
• 108091007433 antigens Proteins 0.000 description 1
• 102000036639 antigens Human genes 0.000 description 1
• 101150089041 aph-1 gene Proteins 0.000 description 1
• 239000007900 aqueous suspension Substances 0.000 description 1
• ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
• 150000004982 aromatic amines Chemical class 0.000 description 1
• 235000003704 aspartic acid Nutrition 0.000 description 1
• 150000001510 aspartic acids Chemical class 0.000 description 1
• DCBDOYDVQJVXOH-UHFFFAOYSA-N azane;1h-indole Chemical compound N.C1=CC=C2NC=CC2=C1 DCBDOYDVQJVXOH-UHFFFAOYSA-N 0.000 description 1
• 230000003542 behavioural effect Effects 0.000 description 1
• JUHORIMYRDESRB-UHFFFAOYSA-N benzathine Chemical class C=1C=CC=CC=1CNCCNCC1=CC=CC=C1 JUHORIMYRDESRB-UHFFFAOYSA-N 0.000 description 1
• SRSXLGNVWSONIS-UHFFFAOYSA-N benzenesulfonic acid Chemical compound OS(=O)(=O)C1=CC=CC=C1 SRSXLGNVWSONIS-UHFFFAOYSA-N 0.000 description 1
• 229940092714 benzenesulfonic acid Drugs 0.000 description 1
• CSKNSYBAZOQPLR-UHFFFAOYSA-N benzenesulfonyl chloride Chemical compound ClS(=O)(=O)C1=CC=CC=C1 CSKNSYBAZOQPLR-UHFFFAOYSA-N 0.000 description 1
• QRUDEWIWKLJBPS-UHFFFAOYSA-N benzotriazole Chemical class C1=CC=C2N[N][N]C2=C1 QRUDEWIWKLJBPS-UHFFFAOYSA-N 0.000 description 1
• 125000002618 bicyclic heterocycle group Chemical group 0.000 description 1
• 239000011230 binding agent Substances 0.000 description 1
• SIPUZPBQZHNSDW-UHFFFAOYSA-N bis(2-methylpropyl)aluminum Chemical compound CC(C)C[Al]CC(C)C SIPUZPBQZHNSDW-UHFFFAOYSA-N 0.000 description 1
• IPWKHHSGDUIRAH-UHFFFAOYSA-N bis(pinacolato)diboron Chemical compound O1C(C)(C)C(C)(C)OB1B1OC(C)(C)C(C)(C)O1 IPWKHHSGDUIRAH-UHFFFAOYSA-N 0.000 description 1
• YNHIGQDRGKUECZ-UHFFFAOYSA-L bis(triphenylphosphine)palladium(ii) dichloride Chemical compound [Cl-].[Cl-].[Pd+2].C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 YNHIGQDRGKUECZ-UHFFFAOYSA-L 0.000 description 1
• 150000001638 boron Chemical class 0.000 description 1
• ODWXUNBKCRECNW-UHFFFAOYSA-M bromocopper(1+) Chemical compound Br[Cu+] ODWXUNBKCRECNW-UHFFFAOYSA-M 0.000 description 1
• HGXJOXHYPGNVNK-UHFFFAOYSA-N butane;ethenoxyethane;tin Chemical compound CCCC[Sn](CCCC)(CCCC)C(=C)OCC HGXJOXHYPGNVNK-UHFFFAOYSA-N 0.000 description 1
• 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
• 150000003940 butylamines Chemical class 0.000 description 1
• FJDQFPXHSGXQBY-UHFFFAOYSA-L caesium carbonate Chemical compound [Cs+].[Cs+].[O-]C([O-])=O FJDQFPXHSGXQBY-UHFFFAOYSA-L 0.000 description 1
• 229910000024 caesium carbonate Inorganic materials 0.000 description 1
• 239000001506 calcium phosphate Substances 0.000 description 1
• 159000000007 calcium salts Chemical class 0.000 description 1
• 239000001569 carbon dioxide Substances 0.000 description 1
• 229910002092 carbon dioxide Inorganic materials 0.000 description 1
• 229910002091 carbon monoxide Inorganic materials 0.000 description 1
• 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
• 239000001768 carboxy methyl cellulose Substances 0.000 description 1
• 201000011529 cardiovascular cancer Diseases 0.000 description 1
• 239000000969 carrier Substances 0.000 description 1
• 210000003710 cerebral cortex Anatomy 0.000 description 1
• KXZJHVJKXJLBKO-UHFFFAOYSA-N chembl1408157 Chemical compound N=1C2=CC=CC=C2C(C(=O)O)=CC=1C1=CC=C(O)C=C1 KXZJHVJKXJLBKO-UHFFFAOYSA-N 0.000 description 1
• 238000012822 chemical development Methods 0.000 description 1
• 239000007795 chemical reaction product Substances 0.000 description 1
• 229940089960 chloroacetate Drugs 0.000 description 1
• FOCAUTSVDIKZOP-UHFFFAOYSA-M chloroacetate Chemical compound [O-]C(=O)CCl FOCAUTSVDIKZOP-UHFFFAOYSA-M 0.000 description 1
• FOCAUTSVDIKZOP-UHFFFAOYSA-N chloroacetic acid Chemical compound OC(=O)CCl FOCAUTSVDIKZOP-UHFFFAOYSA-N 0.000 description 1
• 229940106681 chloroacetic acid Drugs 0.000 description 1
• 238000004587 chromatography analysis Methods 0.000 description 1
• 235000015165 citric acid Nutrition 0.000 description 1
• 230000019771 cognition Effects 0.000 description 1
• 238000004440 column chromatography Methods 0.000 description 1
• 238000002648 combination therapy Methods 0.000 description 1
• 229940125773 compound 10 Drugs 0.000 description 1
• 229940126543 compound 14 Drugs 0.000 description 1
• 229940126540 compound 41 Drugs 0.000 description 1
• 229940125936 compound 42 Drugs 0.000 description 1
• 229940126545 compound 53 Drugs 0.000 description 1
• 229940127113 compound 57 Drugs 0.000 description 1
• GBRBMTNGQBKBQE-UHFFFAOYSA-L copper;diiodide Chemical compound I[Cu]I GBRBMTNGQBKBQE-UHFFFAOYSA-L 0.000 description 1
• 235000005687 corn oil Nutrition 0.000 description 1
• 239000002285 corn oil Substances 0.000 description 1
• 235000012343 cottonseed oil Nutrition 0.000 description 1
• 239000002385 cottonseed oil Substances 0.000 description 1
• 239000007822 coupling agent Substances 0.000 description 1
• 238000005859 coupling reaction Methods 0.000 description 1
• 239000013058 crude material Substances 0.000 description 1
• 239000010779 crude oil Substances 0.000 description 1
• 239000013078 crystal Substances 0.000 description 1
• 238000002425 crystallisation Methods 0.000 description 1
• 230000008025 crystallization Effects 0.000 description 1
• 239000000625 cyclamic acid and its Na and Ca salt Substances 0.000 description 1
• 125000000753 cycloalkyl group Chemical group 0.000 description 1
• 125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
• 229940097362 cyclodextrins Drugs 0.000 description 1
• 125000000582 cycloheptyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
• 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
• HCAJEUSONLESMK-UHFFFAOYSA-N cyclohexylsulfamic acid Chemical compound OS(=O)(=O)NC1CCCCC1 HCAJEUSONLESMK-UHFFFAOYSA-N 0.000 description 1
• NXQGGXCHGDYOHB-UHFFFAOYSA-L cyclopenta-1,4-dien-1-yl(diphenyl)phosphane;dichloropalladium;iron(2+) Chemical compound [Fe+2].Cl[Pd]Cl.[CH-]1C=CC(P(C=2C=CC=CC=2)C=2C=CC=CC=2)=C1.[CH-]1C=CC(P(C=2C=CC=CC=2)C=2C=CC=CC=2)=C1 NXQGGXCHGDYOHB-UHFFFAOYSA-L 0.000 description 1
• 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
• 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 description 1
• 230000034994 death Effects 0.000 description 1
• 230000008021 deposition Effects 0.000 description 1
• 238000011161 development Methods 0.000 description 1
• NEFBYIFKOOEVPA-UHFFFAOYSA-K dicalcium phosphate Chemical compound [Ca+2].[Ca+2].[O-]P([O-])([O-])=O NEFBYIFKOOEVPA-UHFFFAOYSA-K 0.000 description 1
• 229940038472 dicalcium phosphate Drugs 0.000 description 1
• 229910000390 dicalcium phosphate Inorganic materials 0.000 description 1
• ZBCBWPMODOFKDW-UHFFFAOYSA-N diethanolamine Chemical compound OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 description 1
• WYACBZDAHNBPPB-UHFFFAOYSA-N diethyl oxalate Chemical compound CCOC(=O)C(=O)OCC WYACBZDAHNBPPB-UHFFFAOYSA-N 0.000 description 1
• XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 1
• 150000002009 diols Chemical class 0.000 description 1
• WEHWNAOGRSTTBQ-UHFFFAOYSA-N dipropylamine Chemical compound CCCNCCC WEHWNAOGRSTTBQ-UHFFFAOYSA-N 0.000 description 1
• 231100000676 disease causative agent Toxicity 0.000 description 1
• 230000006806 disease prevention Effects 0.000 description 1
• 239000007884 disintegrant Substances 0.000 description 1
• 231100000673 dose–response relationship Toxicity 0.000 description 1
• 238000007876 drug discovery Methods 0.000 description 1
• 230000009977 dual effect Effects 0.000 description 1
• 230000008030 elimination Effects 0.000 description 1
• 238000003379 elimination reaction Methods 0.000 description 1
• 238000010828 elution Methods 0.000 description 1
• 239000000839 emulsion Substances 0.000 description 1
• 231100000317 environmental toxin Toxicity 0.000 description 1
• CCIVGXIOQKPBKL-UHFFFAOYSA-M ethanesulfonate Chemical compound CCS([O-])(=O)=O CCIVGXIOQKPBKL-UHFFFAOYSA-M 0.000 description 1
• QQXQAEWRSVZPJM-UHFFFAOYSA-N ethyl 1h-indole-2-carboxylate Chemical compound C1=CC=C2NC(C(=O)OCC)=CC2=C1 QQXQAEWRSVZPJM-UHFFFAOYSA-N 0.000 description 1
• JOSSZRPXOBWRQT-UHFFFAOYSA-N ethyl 2,2,2-trichloroethanimidate Chemical compound CCOC(=N)C(Cl)(Cl)Cl JOSSZRPXOBWRQT-UHFFFAOYSA-N 0.000 description 1
• BOTXQJAHRCGJEG-UHFFFAOYSA-N ethyl 5-methyl-1h-pyrazole-3-carboxylate Chemical compound CCOC(=O)C=1C=C(C)NN=1 BOTXQJAHRCGJEG-UHFFFAOYSA-N 0.000 description 1
• 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
• BDTDECDAHYOJRO-UHFFFAOYSA-N ethyl n-(sulfanylidenemethylidene)carbamate Chemical compound CCOC(=O)N=C=S BDTDECDAHYOJRO-UHFFFAOYSA-N 0.000 description 1
• 238000001704 evaporation Methods 0.000 description 1
• 230000008020 evaporation Effects 0.000 description 1
• 238000000605 extraction Methods 0.000 description 1
• 238000001914 filtration Methods 0.000 description 1
• 239000012467 final product Substances 0.000 description 1
• 238000003682 fluorination reaction Methods 0.000 description 1
• 229910052731 fluorine Inorganic materials 0.000 description 1
• 239000001530 fumaric acid Substances 0.000 description 1
• 235000011087 fumaric acid Nutrition 0.000 description 1
• 230000006870 function Effects 0.000 description 1
• 239000003540 gamma secretase inhibitor Substances 0.000 description 1
• 238000002290 gas chromatography-mass spectrometry Methods 0.000 description 1
• 230000002496 gastric effect Effects 0.000 description 1
• 238000012252 genetic analysis Methods 0.000 description 1
• ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
• 150000002314 glycerols Chemical class 0.000 description 1
• 229960004275 glycolic acid Drugs 0.000 description 1
• 150000002334 glycols Chemical class 0.000 description 1
• 238000010438 heat treatment Methods 0.000 description 1
• 150000002391 heterocyclic compounds Chemical class 0.000 description 1
• XGIHQYAWBCFNPY-AZOCGYLKSA-N hydrabamine Chemical class C([C@@H]12)CC3=CC(C(C)C)=CC=C3[C@@]2(C)CCC[C@@]1(C)CNCCNC[C@@]1(C)[C@@H]2CCC3=CC(C(C)C)=CC=C3[C@@]2(C)CCC1 XGIHQYAWBCFNPY-AZOCGYLKSA-N 0.000 description 1
• 238000005913 hydroamination reaction Methods 0.000 description 1
• 150000002430 hydrocarbons Chemical group 0.000 description 1
• 125000001183 hydrocarbyl group Chemical group 0.000 description 1
• 238000005984 hydrogenation reaction Methods 0.000 description 1
• XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 description 1
• 230000006951 hyperphosphorylation Effects 0.000 description 1
• 238000003384 imaging method Methods 0.000 description 1
• 150000002460 imidazoles Chemical class 0.000 description 1
• 150000005232 imidazopyridines Chemical class 0.000 description 1
• 238000003018 immunoassay Methods 0.000 description 1
• 238000000338 in vitro Methods 0.000 description 1
• 238000011065 in-situ storage Methods 0.000 description 1
• 238000010348 incorporation Methods 0.000 description 1
• 125000003453 indazolyl group Chemical class N1N=C(C2=C1C=CC=C2)* 0.000 description 1
• 239000012442 inert solvent Substances 0.000 description 1
• 208000027866 inflammatory disease Diseases 0.000 description 1
• 239000003112 inhibitor Substances 0.000 description 1
• 239000003999 initiator Substances 0.000 description 1
• 229940102223 injectable solution Drugs 0.000 description 1
• 230000000266 injurious effect Effects 0.000 description 1
• 150000007529 inorganic bases Chemical class 0.000 description 1
• 230000003834 intracellular effect Effects 0.000 description 1
• 229910052740 iodine Inorganic materials 0.000 description 1
• 239000011630 iodine Substances 0.000 description 1
• 125000002346 iodo group Chemical group I* 0.000 description 1
• INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 1
• 229910052742 iron Inorganic materials 0.000 description 1
• 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
• 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
• 230000000155 isotopic effect Effects 0.000 description 1
• ZLVXBBHTMQJRSX-VMGNSXQWSA-N jdtic Chemical compound C1([C@]2(C)CCN(C[C@@H]2C)C[C@H](C(C)C)NC(=O)[C@@H]2NCC3=CC(O)=CC=C3C2)=CC=CC(O)=C1 ZLVXBBHTMQJRSX-VMGNSXQWSA-N 0.000 description 1
• NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
• 239000004310 lactic acid Substances 0.000 description 1
• 235000014655 lactic acid Nutrition 0.000 description 1
• 229960000448 lactic acid Drugs 0.000 description 1
• 239000008101 lactose Substances 0.000 description 1
• 229940039717 lanolin Drugs 0.000 description 1
• 235000019388 lanolin Nutrition 0.000 description 1
• 230000003902 lesion Effects 0.000 description 1
• 230000000670 limiting effect Effects 0.000 description 1
• 238000004895 liquid chromatography mass spectrometry Methods 0.000 description 1
• 229910052744 lithium Inorganic materials 0.000 description 1
• DLEDOFVPSDKWEF-UHFFFAOYSA-N lithium butane Chemical compound [Li+].CCC[CH2-] DLEDOFVPSDKWEF-UHFFFAOYSA-N 0.000 description 1
• RENRQMCACQEWFC-UGKGYDQZSA-N lnp023 Chemical compound C1([C@H]2N(CC=3C=4C=CNC=4C(C)=CC=3OC)CC[C@@H](C2)OCC)=CC=C(C(O)=O)C=C1 RENRQMCACQEWFC-UGKGYDQZSA-N 0.000 description 1
• 150000004668 long chain fatty acids Chemical class 0.000 description 1
• 231100000863 loss of memory Toxicity 0.000 description 1
• 239000000314 lubricant Substances 0.000 description 1
• 239000011777 magnesium Substances 0.000 description 1
• 229910052749 magnesium Inorganic materials 0.000 description 1
• 235000019359 magnesium stearate Nutrition 0.000 description 1
• 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
• 235000019341 magnesium sulphate Nutrition 0.000 description 1
• VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
• 239000011976 maleic acid Substances 0.000 description 1
• 239000001630 malic acid Substances 0.000 description 1
• 235000011090 malic acid Nutrition 0.000 description 1
• 239000000463 material Substances 0.000 description 1
• 230000007246 mechanism Effects 0.000 description 1
• 230000001404 mediated effect Effects 0.000 description 1
• 239000012528 membrane Substances 0.000 description 1
• 230000002503 metabolic effect Effects 0.000 description 1
• 229910052751 metal Inorganic materials 0.000 description 1
• 239000002184 metal Substances 0.000 description 1
• UKVIEHSSVKSQBA-UHFFFAOYSA-N methane;palladium Chemical compound C.[Pd] UKVIEHSSVKSQBA-UHFFFAOYSA-N 0.000 description 1
• 229940098779 methanesulfonic acid Drugs 0.000 description 1
• RXYCUKSOYJWGPE-UHFFFAOYSA-N methyl 2-azidoacetate Chemical compound COC(=O)CN=[N+]=[N-] RXYCUKSOYJWGPE-UHFFFAOYSA-N 0.000 description 1
• GRVDJDISBSALJP-UHFFFAOYSA-N methyloxidanyl Chemical group [O]C GRVDJDISBSALJP-UHFFFAOYSA-N 0.000 description 1
• 150000007522 mineralic acids Chemical class 0.000 description 1
• 230000004048 modification Effects 0.000 description 1
• 238000012986 modification Methods 0.000 description 1
• 239000003607 modifier Substances 0.000 description 1
• 230000009456 molecular mechanism Effects 0.000 description 1
• KVKFRMCSXWQSNT-UHFFFAOYSA-N n,n'-dimethylethane-1,2-diamine Chemical compound CNCCNC KVKFRMCSXWQSNT-UHFFFAOYSA-N 0.000 description 1
• DUWWHGPELOTTOE-UHFFFAOYSA-N n-(5-chloro-2,4-dimethoxyphenyl)-3-oxobutanamide Chemical compound COC1=CC(OC)=C(NC(=O)CC(C)=O)C=C1Cl DUWWHGPELOTTOE-UHFFFAOYSA-N 0.000 description 1
• 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
• GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
• 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
• XBXCNNQPRYLIDE-UHFFFAOYSA-M n-tert-butylcarbamate Chemical compound CC(C)(C)NC([O-])=O XBXCNNQPRYLIDE-UHFFFAOYSA-M 0.000 description 1
• IOMMMLWIABWRKL-WUTDNEBXSA-N nazartinib Chemical compound C1N(C(=O)/C=C/CN(C)C)CCCC[C@H]1N1C2=C(Cl)C=CC=C2N=C1NC(=O)C1=CC=NC(C)=C1 IOMMMLWIABWRKL-WUTDNEBXSA-N 0.000 description 1
• 230000004770 neurodegeneration Effects 0.000 description 1
• 208000015122 neurodegenerative disease Diseases 0.000 description 1
• 210000002682 neurofibrillary tangle Anatomy 0.000 description 1
• 230000002981 neuropathic effect Effects 0.000 description 1
• 231100000189 neurotoxic Toxicity 0.000 description 1
• 230000002887 neurotoxic effect Effects 0.000 description 1
• 229910017604 nitric acid Inorganic materials 0.000 description 1
• 239000000041 non-steroidal anti-inflammatory agent Substances 0.000 description 1
• 238000001208 nuclear magnetic resonance pulse sequence Methods 0.000 description 1
• 235000015097 nutrients Nutrition 0.000 description 1
• 239000006186 oral dosage form Substances 0.000 description 1
• 239000010502 orange oil Substances 0.000 description 1
• 201000008482 osteoarthritis Diseases 0.000 description 1
• 235000006408 oxalic acid Nutrition 0.000 description 1
• 229940116315 oxalic acid Drugs 0.000 description 1
• WLJNZVDCPSBLRP-UHFFFAOYSA-N pamoic acid Chemical compound C1=CC=C2C(CC=3C4=CC=CC=C4C=C(C=3O)C(=O)O)=C(O)C(C(O)=O)=CC2=C1 WLJNZVDCPSBLRP-UHFFFAOYSA-N 0.000 description 1
• FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
• 229920002866 paraformaldehyde Polymers 0.000 description 1
• 230000036961 partial effect Effects 0.000 description 1
• 239000002245 particle Substances 0.000 description 1
• 230000001575 pathological effect Effects 0.000 description 1
• 230000007170 pathology Effects 0.000 description 1
• 239000000312 peanut oil Substances 0.000 description 1
• 239000003961 penetration enhancing agent Substances 0.000 description 1
• 239000012026 peptide coupling reagents‎ Substances 0.000 description 1
• 235000019271 petrolatum Nutrition 0.000 description 1
• CYQAYERJWZKYML-UHFFFAOYSA-N phosphorus pentasulfide Chemical compound S1P(S2)(=S)SP3(=S)SP1(=S)SP2(=S)S3 CYQAYERJWZKYML-UHFFFAOYSA-N 0.000 description 1
• 239000000902 placebo Substances 0.000 description 1
• 229940068196 placebo Drugs 0.000 description 1
• 229920000166 polytrimethylene carbonate Polymers 0.000 description 1
• 239000011591 potassium Substances 0.000 description 1
• 229910052700 potassium Inorganic materials 0.000 description 1
• 235000011056 potassium acetate Nutrition 0.000 description 1
• 229910000027 potassium carbonate Inorganic materials 0.000 description 1
• RPDAUEIUDPHABB-UHFFFAOYSA-N potassium ethoxide Chemical compound [K+].CC[O-] RPDAUEIUDPHABB-UHFFFAOYSA-N 0.000 description 1
• LPNYRYFBWFDTMA-UHFFFAOYSA-N potassium tert-butoxide Chemical compound [K+].CC(C)(C)[O-] LPNYRYFBWFDTMA-UHFFFAOYSA-N 0.000 description 1
• VZOPRCCTKLAGPN-ZFJVMAEJSA-L potassium;sodium;(2r,3r)-2,3-dihydroxybutanedioate;tetrahydrate Chemical compound O.O.O.O.[Na+].[K+].[O-]C(=O)[C@H](O)[C@@H](O)C([O-])=O VZOPRCCTKLAGPN-ZFJVMAEJSA-L 0.000 description 1
• 229920001592 potato starch Polymers 0.000 description 1
• 230000002028 premature Effects 0.000 description 1
• 230000000750 progressive effect Effects 0.000 description 1
• 229940018489 pronto Drugs 0.000 description 1
• VVWRJUBEIPHGQF-UHFFFAOYSA-N propan-2-yl n-propan-2-yloxycarbonyliminocarbamate Chemical compound CC(C)OC(=O)N=NC(=O)OC(C)C VVWRJUBEIPHGQF-UHFFFAOYSA-N 0.000 description 1
• 235000019260 propionic acid Nutrition 0.000 description 1
• 230000001681 protective effect Effects 0.000 description 1
• 238000000425 proton nuclear magnetic resonance spectrum Methods 0.000 description 1
• 229940107700 pyruvic acid Drugs 0.000 description 1
• 230000000171 quenching effect Effects 0.000 description 1
• SBYHFKPVCBCYGV-UHFFFAOYSA-N quinuclidine Chemical compound C1CC2CCN1CC2 SBYHFKPVCBCYGV-UHFFFAOYSA-N 0.000 description 1
• 238000003346 radioligand binding method Methods 0.000 description 1
• 239000012429 reaction media Substances 0.000 description 1
• 238000000611 regression analysis Methods 0.000 description 1
• 238000011160 research Methods 0.000 description 1
• 230000002441 reversible effect Effects 0.000 description 1
• 238000007363 ring formation reaction Methods 0.000 description 1
• 229960004889 salicylic acid Drugs 0.000 description 1
• 239000012266 salt solution Substances 0.000 description 1
• 229930195734 saturated hydrocarbon Natural products 0.000 description 1
• 239000012047 saturated solution Substances 0.000 description 1
• 230000009962 secretion pathway Effects 0.000 description 1
• 239000008159 sesame oil Substances 0.000 description 1
• 235000011803 sesame oil Nutrition 0.000 description 1
• 108091006024 signal transducing proteins Proteins 0.000 description 1
• 102000034285 signal transducing proteins Human genes 0.000 description 1
• 239000002002 slurry Substances 0.000 description 1
• WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 1
• 239000004299 sodium benzoate Substances 0.000 description 1
• 235000010234 sodium benzoate Nutrition 0.000 description 1
• 235000017557 sodium bicarbonate Nutrition 0.000 description 1
• 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
• 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
• 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
• BEOOHQFXGBMRKU-UHFFFAOYSA-N sodium cyanoborohydride Chemical compound [Na+].[B-]C#N BEOOHQFXGBMRKU-UHFFFAOYSA-N 0.000 description 1
• QDRKDTQENPPHOJ-UHFFFAOYSA-N sodium ethoxide Chemical compound [Na+].CC[O-] QDRKDTQENPPHOJ-UHFFFAOYSA-N 0.000 description 1
• 239000012312 sodium hydride Substances 0.000 description 1
• 235000010267 sodium hydrogen sulphite Nutrition 0.000 description 1
• 235000010288 sodium nitrite Nutrition 0.000 description 1
• 235000011006 sodium potassium tartrate Nutrition 0.000 description 1
• 229910052938 sodium sulfate Inorganic materials 0.000 description 1
• 235000011152 sodium sulphate Nutrition 0.000 description 1
• AKHNMLFCWUSKQB-UHFFFAOYSA-L sodium thiosulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=S AKHNMLFCWUSKQB-UHFFFAOYSA-L 0.000 description 1
• 235000019345 sodium thiosulphate Nutrition 0.000 description 1
• 239000008279 sol Substances 0.000 description 1
• 239000000600 sorbitol Substances 0.000 description 1
• 239000003549 soybean oil Substances 0.000 description 1
• 235000012424 soybean oil Nutrition 0.000 description 1
• VNFWTIYUKDMAOP-UHFFFAOYSA-N sphos Chemical group COC1=CC=CC(OC)=C1C1=CC=CC=C1P(C1CCCCC1)C1CCCCC1 VNFWTIYUKDMAOP-UHFFFAOYSA-N 0.000 description 1
• 239000004544 spot-on Substances 0.000 description 1
• 239000008107 starch Substances 0.000 description 1
• 235000019698 starch Nutrition 0.000 description 1
• 230000000707 stereoselective effect Effects 0.000 description 1
• 239000008223 sterile water Substances 0.000 description 1
• 239000001384 succinic acid Substances 0.000 description 1
• 235000000346 sugar Nutrition 0.000 description 1
• 150000008163 sugars Chemical class 0.000 description 1
• 229910052717 sulfur Inorganic materials 0.000 description 1
• 239000011593 sulfur Substances 0.000 description 1
• UDYFLDICVHJSOY-UHFFFAOYSA-N sulfur trioxide-pyridine complex Substances O=S(=O)=O.C1=CC=NC=C1 UDYFLDICVHJSOY-UHFFFAOYSA-N 0.000 description 1
• 239000000829 suppository Substances 0.000 description 1
• 239000000375 suspending agent Substances 0.000 description 1
• 238000013268 sustained release Methods 0.000 description 1
• 239000012730 sustained-release form Substances 0.000 description 1
• 208000011580 syndromic disease Diseases 0.000 description 1
• 238000010189 synthetic method Methods 0.000 description 1
• 239000006188 syrup Substances 0.000 description 1
• 235000020357 syrup Nutrition 0.000 description 1
• 238000007910 systemic administration Methods 0.000 description 1
• 229940042055 systemic antimycotics triazole derivative Drugs 0.000 description 1
• 230000009885 systemic effect Effects 0.000 description 1
• 239000000454 talc Substances 0.000 description 1
• 229910052623 talc Inorganic materials 0.000 description 1
• 239000011975 tartaric acid Substances 0.000 description 1
• 235000002906 tartaric acid Nutrition 0.000 description 1
• 102000013498 tau Proteins Human genes 0.000 description 1
• 108010026424 tau Proteins Proteins 0.000 description 1
• 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
• DKACXUFSLUYRFU-UHFFFAOYSA-N tert-butyl n-aminocarbamate Chemical compound CC(C)(C)OC(=O)NN DKACXUFSLUYRFU-UHFFFAOYSA-N 0.000 description 1
• 125000005931 tert-butyloxycarbonyl group Chemical group [H]C([H])([H])C(OC(*)=O)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
• 150000003510 tertiary aliphatic amines Chemical class 0.000 description 1
• YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
• 125000001412 tetrahydropyranyl group Chemical group 0.000 description 1
• CZDYPVPMEAXLPK-UHFFFAOYSA-N tetramethylsilane Chemical compound C[Si](C)(C)C CZDYPVPMEAXLPK-UHFFFAOYSA-N 0.000 description 1
• 231100000419 toxicity Toxicity 0.000 description 1
• 230000001988 toxicity Effects 0.000 description 1
• 238000012546 transfer Methods 0.000 description 1
• 230000032258 transport Effects 0.000 description 1
• 150000003852 triazoles Chemical class 0.000 description 1
• CWMFRHBXRUITQE-UHFFFAOYSA-N trimethylsilylacetylene Chemical group C[Si](C)(C)C#C CWMFRHBXRUITQE-UHFFFAOYSA-N 0.000 description 1
• 238000001665 trituration Methods 0.000 description 1
• 239000003039 volatile agent Substances 0.000 description 1
• 239000000080 wetting agent Substances 0.000 description 1
• 239000003871 white petrolatum Substances 0.000 description 1
• 229910052725 zinc Inorganic materials 0.000 description 1